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ABSTRACT 
 
 
 
USING THE FROG EPIDERMIS TO UNCOVER DESMOSOME FUNCTION AND 
REGULATION IN THE DEVELOPING EMBRYO 
 
By Navaneetha Krishnan Bharathan, Ph.D. 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University 
 
Virginia Commonwealth University, 2018 
 
Major Director: Dr. Amanda J. Dickinson 
Assistant Professor, Department of Human and Molecular Genetics 
 
 
The desmosome is one of the major cell adhesion junctions found in the epithelia, heart, 
and hair follicle. Described as a “rivet” that hold cells together, it provides these tissues with the 
integrity to withstand the tremendous forces they face in everyday life. Defects in this junction can 
lead to devastating diseases where patients are susceptible to skin infections and cardiovascular 
defects. Limited treatments exist for diseases of the desmosome, and strategies do not target all 
symptoms. Therefore, delineating the function and regulation of desmosomes is of paramount 
importance for the development of prevention and treatment strategies. The Xenopus laevis has 
been utilized for the study of embryonic development and tissue movements. This study takes 
advantage of the frog model to study a key desmosomal protein, desmoplakin (Dsp), in the 
xv 
 
 
 
epidermal development of the embryo. First, Xenopus embryonic epidermis has junctiona l 
desmosomes as early as the blastula stages. Desmosomes numbers per junction increase as the 
embryo develops. Dsp is present in many epidermally-derived structures in the embryo at varying 
levels. Xenopus embryos deficient in desmoplakin have phenotypic defects in epidermal structures 
and the heart, mimicking mammalian models. Embryos with reduced Dsp exhibit an increased 
susceptibility to epidermal damage under applied mechanical forces. Assays also reveal a potential 
role for desmosomes in radial intercalation, a process through which cells move from the inner to 
the outer epidermal layers. Embryos with reduced Dsp exhibit a slight reduction in intercala t ion 
and defects in intercalating cell types, including multiciliated cells and small secretory cells. 
Finally, c-Jun N-terminal kinase (JNK) may have a potential role in the regulation of desmosome 
assembly and adhesion. Embryos with deficient Dsp display a partial recovery of mechanica l 
integrity when treated with a JNK inhibitor. 
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CHAPTER 1: THE ROLE AND REGULATION OF DESMOSOMES IN THE XENOPUS 
LAEVIS EMBRYONIC EPIDERMIS 
INTRODUCTION 
 
 
 
Desmosomes or macula adherens are junctional complexes that mediate cell-cell adhesion, 
along with tight junctions and adherens junctions. Their strong adhesion confers the mechanica l 
integrity to withstand stresses experienced by the skin and heart (Collins and Garrod, 1994; 
Garrod, 1993). Desmosome function has largely been investigated in the context of cell adhesion 
and disease. As a consequence, little is known regarding the regulation of desmosomes during 
development in vivo and their function in morphogenesis. The current study makes use of the 
vertebrate frog model, Xenopus laevis, to investigate desmosome function and regulation during 
embryonic development. 
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XENOPUS LAEVIS AS A MODEL ORGANISM 
The African clawed frog, Xenopus laevis, is an allotetraploid aquatic amphibian species of 
the order Anura. Over the last 100 years, this species along with the related diploid species, 
Xenopus tropicalis  ¸ have been extensively utilized for biological research and medical 
applications. For example, these organisms have been used to study various aspects of cellular and 
developmental biology including gastrulation, cell movements, and signaling pathways (Tandon 
et al., 2017). 
Xenopus laevis possesses many characteristics that have led to its emergence as a model 
organism. First, many embryos (500-2000+) can be obtained in a single clutch, providing statistica l 
power to experiments. Second, the egg size is relatively larger (1-1.3mm) than other aquatic 
vertebrates including X. tropicalis (0.7-0.8mm) and the zebrafish, Danio rerio (0.7mm) (Hirsch et 
al., 2002; Kimmel et al., 1995). The large egg size allows one to easily manipulate the embryo by 
microinjection of morpholinos, mRNA, plasmid constructs, or protein. Over the last decade, the 
genetic manipulation toolkit has expanded to include I-SceI meganuclease, Transcript ion 
Activator-Like Effector Nucleases (TALENs), and CRISPR/ Cas, thus making it possible to create 
genetically manipulated organisms (Ishibashi et al., 2012; Joung and Sander, 2013; Lei et al., 2012; 
Sater and Moody, 2017; Tandon et al., 2017). Third, fate maps for the embryonic blastomeres are 
well-characterized in X. laevis, allowing one to study tissue-specific functions of a gene or protein 
(Dale and Slack, 1987; Moody, 1987; Moody and Kline, 1990). Additionally, external fertiliza t ion 
and detailed staging of early embryonic development make this organism well-suited for the study 
of organogenesis and use in chemical drug screening (Dickinson, 2016; Harland and Grainger, 
2011; Nieuwkoop and Faber, 1967; Schmitt et al., 2014). 
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X. tropicalis is a diploid organism with 2n=20 chromosomes, while X. laevis is an 
allotetraploid organism with 2n=36 chromosomes. Based on protein-coding gene phylogeny, the 
ancestors of X. laevis and X. tropicalis are believed to have diverged around 48-65 Mya (Evans et 
al., 2004; Hellsten et al., 2007; Matsuda et al., 2015; Session et al., 2016). The ancestor of X. laevis, 
now thought to be extinct, had 18 chromosomes (2n) (Evans, 2008), and a whole genome 
duplication (allotetraploidization) event around 17 Mya led to the emergence of X. laevis (Chain 
and Evans, 2006; Evans et al., 2004; Hellsten et al., 2007; Hughes and Hughes, 1993; Session et 
al., 2016).  
The allotetraploidization of X. laevis resulted from the convergence of two 18-chromosome 
species. The genetic contribution of both ancestral species appears to be cytologically distinct from 
each other, forming bivalents instead of quadrivalents during meiosis (Tymowska and Kobel, 
1972; Uno et al., 2013). Recently, these two “subgenomes” were designated “L” (Long) and “S” 
(Short) for their relative differences in chromosome length(Matsuda et al., 2015). Each of the 9 
pairs of chromosomes in the L subgenome are found to be homologous to those in the S subgenome 
based on similarities in chromosome morphology and banding patterns as well as comparative 
phylogenetic mapping (Krylov et al., 2010; Matsuda et al., 2015; Tymowska and Kobel, 1972; 
Uno et al., 2013). Further genetic analysis revealed large deletions in the S subgenome. Genes 
already present in multiple copies are more likely to be retained, such as Hox clusters. However, 
genes involved in DNA repair and metabolic enzymes, for example, are lost, suggesting deletion 
due to selection pressure (Session et al., 2016).  
Despite the allotetraploidy of X. laevis, development and sequencing of the inbred J strain 
has made it a more tractable model (Gantress et al., 2003; Pearl et al., 2012; Session et al., 2016). 
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DEVELOPMENT OF THE EMBRYONIC EPIDERMIS 
The epidermis or skin plays pivotal roles in regulating body temperature as well as 
protection from dehydration and infection. The human epidermis arises as a bi-layer from the 
embryonic surface ectoderm sometime after neurulation (4 weeks) (Breathnach and Wyllie, 1965; 
Holbrook and Odland, 1975). The outer protective layer of cells is called the periderm, and 
functions as the embryonic epidermis in utero until about 5 months (Haslam et al., 2014). The 
periderm is marked by expression of simple epithelial keratins K8/ K18 (Jackson et al., 1981; Moll 
et al., 1982). The inner or basal layer is considered the epidermis proper, expressing K5/ K14 
(Lourenco et al., 2008). This basal layer eventually gives rise to the remaining layers. 
At around 8 weeks, adherens junction proteins including E-cadherin, P-cadherin, α catenin, 
and α actinin are expressed in the bi-layer (Fujita et al., 1992; Hentula et al., 2001; Lourenco et 
al., 2008). Tight junctions are also visible between peridermal cells and ZO-1 and occludin 
expression have been demonstrated (Pummi et al., 2001). During this time, the basal layer 
undergoes mitosis and gives rise to the intermediate cell layer which matures into the spinous layer 
expressing K1/ K10 (Dale et al., 1985). This layer arises from asymmetric cell divisions and a 
spindle shift in the basal layer from lateral to perpendicular (Lechler and Fuchs, 2005).  
Between 9-20 weeks, the number of desmosomes in the spinous layer increases as it 
proliferates (Dale et al., 1985; Holbrook and Odland, 1975). By 21-24 weeks post-coitus, the 
spinous cells proliferate and migrate outward, giving rise to the granular and cornified layers 
(Holbrook, 1983). The granular layer expresses transglutaminase and involucrin, while the 
cornified layer is marked by filaggrin and loricrin expression (Koster and Roop, 2007). Finally, 
keratinization proceeds as the cornified layer becomes flattened and the periderm is shed into the 
amniotic fluid (Holbrook and Odland, 1980). This process leads to the formation of the stratum 
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corneum that functions as a barrier (Liu et al., 2013). This final configuration of the stratified 
epidermis is maintained through adulthood. 
The Xenopus epidermis also develops from a bi-layered ectoderm (Chalmers et al., 2003; 
Itoh et al., 1988). The single- layered 32-cell stage embryo develops an inner layer through 
asymmetrical division (Chalmers et al., 2003). As the embryo progresses into the 1024-cell stage, 
the number of layers increases and eventually thins out to two layers at the animal cap, forming 
the prospective epidermis (Haslam et al., 2014). 
As the embryos progresses through gastrulation (st. 12-15), specialized cell types are 
specified in both layers. The outer layer eventually forms mucus-secreting goblet cells. During 
neurulation (st. 19), the specified cell types of the inner layer integrate into the goblet cells of the 
outer layer (Deblandre et al., 1999). The inner basal layer is maintained in a proliferative state, 
similar to the mammalian embryonic epidermis. The Xenopus epidermis remains as a bi-layer until 
metamorphosis. 
During metamorphosis, the basal layer proliferates further and gives rise to the five-layered 
adult skin (Duellman and Trueb, 1994; Itoh et al., 1988). Xenopus epidermis can also become 
keratinized (stratum corneum) like that of mammals, although to a lesser extent. However, this 
corneal layer is not present in fish, marking the evolutionary transition from aquatic to terrestrial 
life (Fox, 1986; Schempp et al., 2009). Together, these similarities make the Xenopus epidermis a 
suitable model for the study of embryonic development in general. 
The specialized cell types in the Xenopus embryonic epidermis include the multiciliated 
cells, ionocytes, and small secretory cells. These cells move from the inner to the outer epidermal 
layer through a process known as radial intercalation. While these cell types are not present in the 
mammalian epidermis, they are found in other epithelia (Billett and Gould, 1971). For example, 
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multiciliated cells are found lining the human airways (Hayes et al., 2007). Ionocyte-like cells are 
found in transporting epithelia of the mammalian kidney (Oliver, 1944; Wall, 2005). These 
features validate the use of Xenopus embryonic epidermis as a model for radial intercalation and 
the development of specialized epithelia. 
 
RADIAL INTERCALATION IN THE XENOPUS EPIDERMIS 
Radial intercalation is a process by which cells in adjacent layers throughout a multilayered 
tissue exchange places with each another (Walck-Shannon and Hardin, 2014). This process is 
known to occur in Drosophila melanogaster mesoderm to facilitate spreading, eventually forming 
a monolayer (Clark et al., 2011; McMahon et al., 2010; McMahon et al., 2008). Deep cells in the 
zebrafish embryo undergo radial intercalation to drive epiboly (Kane et al., 2005). In the 
gastrulating Xenopus embryo, these movements occur in the chordamesoderm (Wilson and Keller, 
1991).  
The Xenopus embryonic epidermis also undergoes radial intercalation. The outcome of 
these movements is the incorporation of specialized cell types into the outer epidermal layer at two 
separate timepoints. Development of these cell types in the bi-layered ectoderm occurs through 
four major steps. First, precursors of ionocytes and multiciliated cells are specified in the inner 
layer of the ectoderm during gastrulation. At the same time, the outer layer is specified into goblet 
cells. Second, ionocytes and multiciliated cells intercalate into the outer layer beginning at 
neurulation. Third, these cells fully differentiate once they have been apically “docked” into their 
final position (Deblandre et al., 1999). Finally, small secretory cells intercalate into the outer layer 
during a second wave of intercalation (Cibois et al., 2014; Dubaissi et al., 2014). Many factors are 
involved in the specification, intercalation, and differentiation of each of the cell types. 
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Lateral inhibition through the Notch pathway restricts the fate of precursors in the inner 
layer (Deblandre et al., 1999; Drysdale and Elinson, 1992). Cells expressing the Notch ligand, 
Delta-1, adopt the differentiated cell fate while repressing this fate in neighboring cells where it 
activates the Notch receptor (Bray, 2006; Deblandre et al., 1999). This mechanism results in an 
organized spacing pattern of these cells. 
The specification of the different cell types is controlled by many factors. In multiciliated 
cell specification, Notch pathway inhibition leads to activation of Multicilin, a transcriptiona l 
regulator that is necessary and sufficient for the multiciliated cell fate (Stubbs et al., 2012). Gmnc 
(geminin coiled-coil domain containing) has been identified as an upstream activator of multic il in 
(Zhou et al., 2015). Multicilin in turn activates FoxJ1, a master regulator of motile ciliogenes is 
(Stubbs et al., 2008). Additionally, the transcription factor, Rfx2, targets genes involved in cilia 
assembly, motility, and planar polarization of directional beating (Chung et al., 2014; Chung et al., 
2012). Other factors that are expressed in ciliated cell precursors, such as Sox7, may also play 
roles in differentiation (Fawcett and Klymkowsky, 2004). The differentiated multiciliated cell 
facilitates mucus-clearance from the epidermis and might also help in oxygen uptake through the 
skin before hatching (Billett and Gould, 1971; Deblandre et al., 1999; Mueller and Seymour, 
2011). 
Ionocytes are also specified by Notch inhibitory signaling through another target, FoxI1e. 
This transcription factor can activate genes encoding proton-pump subunits and anion antiporters 
such as pendrin and ae1. Additionally, expression of grainyhead- like transcription factor ubp1 can 
regulate the formation of alpha- and beta-subtypes (Quigley et al., 2011). Ionocytes are required 
for ionic regulation of the embryo and also have non-autonomous roles in proper development of 
cilia in multiciliated cells (Dubaissi and Papalopulu, 2011). 
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Multiciliated cells and ionocytes are specified during gastrulation and intercalate during 
neurulation (st. 15-19). However, small secretory cells intercalate sometime after embryonic 
hatching (st. 32). Development of these cells is controlled by Foxa1. The Lectin Peanut Agglut inin 
(Lectin PNA) binds the carbohydrate sequence Gal-β(1-3)-GalNAc present in vesicular secretions 
and can be used to identify these cells. Mass spectrometry analysis of this material revealed 
glycosylated Otoglein- like protein which may contribute to the protective mucus layer on the 
epidermis (Dubaissi et al., 2014). Together, all these specialized cell types are thought to work in 
concert to provide resistance to bacterial infections (Stubbs et al., 2006). 
 
ADHERENS AND TIGHT JUNCTIONS 
 The intercellular junctions in epithelial and endothelial tissues comprise the tight junctions 
(zonula occludens), adherens junctions (zonula adherens), the desmosomes (macula adherens), 
and gap junctions. The first three junctions help maintain an adhesive tissue. In the skin, adherens 
junctions play a vital role in intercellular adhesion. However, they also mediate intracellular 
signaling, cell polarity, and cell sorting (Gottardi et al., 2001; Niessen and Gottardi, 2008; Perrais 
et al., 2007; Wang and Margolis, 2007; Wei et al., 2005). Tight junctions serve as a semi-permeab le 
barrier in the skin where they protect against trans-epidermal water loss (Furuse et al., 2002; Hadj-
Rabia et al., 2004; Niessen, 2007). Tight junctions also function as a paracellular barrier, restricting 
flow based on size and charge (Larre et al., 2014). Also similar to adherens junctions, tight 
junctions can participate in signaling pathways (Gonzalez-Mariscal et al., 2014; Zihni et al., 2014).  
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THE DESMOSOME AND ITS COMPONENTS 
The desmosome appears as an electron dense structure in an electron micrograph and 
consists of 3 main families of proteins - cadherins, armadillo proteins, and the plakins (Fig. 1.1). 
The desmosomal cadherins, desmogleins (Dsg) and desmocollins (Dsc), form the transmembrane 
components of the desmosome. In humans and mice, four desmoglein genes (Dsg 1-4) and three 
desmocollin genes (Dsc 1-3) have been identified. Furthermore, all three desmocollins are 
alternatively spliced into two distinct isoforms (a and b) (Collins et al., 1991; Parker et al., 1991). 
Depending on tissue type and availability, the desmosomal cadherins can form homo- or hetero-
dimers in a cis- fashion and bind to apposing cadherins in a trans- fashion (Delva et al., 2009; 
Green and Simpson, 2007). 
The desmosomal cadherins are made up of several functional domains. At the N-terminus, 
there are extracellular subdomains including four extracellular cadherin domains (EC1-4) which 
are required for dimerization (Pokutta and Weis, 2007). The presence of a cell adhesion recognit ion 
(CAR) site contributes to adhesion. At the C-terminal region of desmogleins and the “a” isoform 
of desmocollins, there is an intracellular cadherin-like sequence (ICS) domain. In the desmocollin 
“b” isoform, this domain is truncated and has additional unique amino acids. The ICS domain 
enables binding to the armadillo protein, plakoglobin (Pg) (Mathur et al., 1994; Roh and Stanley, 
1995; Troyanovsky et al., 1994). 
The armadillo family of proteins, among others, include β-catenin, α-catenin, p-120 
catenin, plakoglobin (γ-catenin), and the plakophilins. They are named for the presence of 
distinctive armadillo repeats of a ~42 amino acid motif (Peifer et al., 1994; Peifer et al., 1992). In 
the desmosome, plakoglobin (Pg) and plakophilin (Pkp) are present and attach to the cytopla smic 
tail of the desmogleins and desmocollins (Kowalczyk et al., 1994; Mathur et al., 1994).  
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Plakoglobin is analogous to β-catenin in the adherens junction (Butz et al., 1992; McCrea 
et al., 1991). It has also been found to associate with both desmosomes and adherens junctions 
(Cowin et al., 1986). Additionally, plakoglobin has some overlapping roles with β-catenin, and 
can bind to TCF/ LEF factors (Simcha et al., 1998; Zhurinsky et al., 2000). In humans, there are 
three plakophilin genes (Pkp 1-3) which have differential expression in epithelial and cardiac 
tissues. For example, Pkp1 is expressed in the suprabasal layers of the multi-layered epidermis, 
whereas Pkp2 is expressed more ubiquitously in simple, stratified, and complex epithelia, as well 
as cardiomyocytes (Hatzfeld, 2007; Hatzfeld et al., 1994; Kapprell et al., 1988; Mertens et al., 
1996; Mertens et al., 1999; Schmidt et al., 1997). Plakophilin 3 is expressed in most simple and 
stratified epithelia and is expressed in all epidermal layers (Bonne et al., 1999). All three 
plakophilins have two alternatively spliced isoforms (a and b) (Mertens et al., 1996; Muhmer et 
al., 2014; Schmidt et al., 1997). Plakophilins are found to associate with desmosomal cadherins, 
plakoglobin, desmoplakin, and even the intermediate filaments, indicating that they are important 
desmosomal proteins (Hatzfeld, 2007) 
The plakin family of desmosomal proteins include desmoplakin (Dsp), epiplakin (Epi), 
periplakin (Ppl), envoplakin (Evpl), plectin, and BPAG (bullous pemphigoid antigen) to name a 
few. Proteins in this family bind to the underlying cytoskeleton mainly to intermediate filaments 
(IF). Through this interaction, they tether the IF to cell-cell or cell-matrix junctions (Green et al., 
1992; Stappenbeck et al., 1993). Some plakins have also been found to interact with actin and 
microtubules (Roper et al., 2002). Plakins have characteristic domains which enable them to 
dimerize (such as the alpha-helical coiled-coil domain) and to attach to intermediate filaments 
(such as the plakin repeat domains (PRD)) (Jefferson et al., 2004; Leung et al., 2002). At the N-
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terminal region, Dsp, for example, has a plakin domain comprising spectrin repeats (Virata et al., 
1992). 
The intermediate filaments comprise several cytoskeletal proteins including epithelia l 
keratins, mesenchymal vimentin, muscle desmin, and the nuclear lamins (Conway and Parry, 
1988; Herrmann and Aebi, 1998). They are so named because their average diameter (10nm) lies 
between the diameters of the other two major cytoskeletal proteins, actin microfilaments (7nm) 
and microtubules (25nm). Most IFs have a 45nm central α-helical rod domain flanked by non-α-
helical domains. The epithelial keratins are made up of Type I (acidic) and Type II (basic) keratins 
that form heterodimers. The first step is the formation of a coiled-coil dimer of the Type I and 
Type II keratins stabilized by a cysteine cross-link (Hatzfeld and Weber, 1990). This step is 
followed by anti-parallel association of dimers forming a tetramer, called a protofilament (Steinert 
et al., 1993). These units further dimerize and tetramerize to form the keratin filament (Aebi et al., 
1988; Goldie et al., 2007; Herrmann et al., 2009). Humans have over 60 epithelial keratins which 
are expressed in a cell-type specific manner. For example, K5/ K14 are expressed in the 
proliferating basal layer of the epidermis, while K1/K10 are expressed in the differentiated 
suprabasal layers (Fuchs and Green, 1980; Roop et al., 1987). Each keratin is vital to normal 
embryonic development, with little compensation by the remaining keratins.  For example, K14 
knockout mice have postnatal lethality with extensive blistering (Chan et al., 1994). K1/ K10 
double knockout mice also have postnatal lethality probably due to loss of nuclear integrity during 
differentiation (Wallace et al., 2012). Together, these proteins provide integrity to the cell and 
mechano-transduction, i.e., generation of molecular signals in response to a mechanical stimulus 
(Brooke et al., 2012; Green and Simpson, 2007). 
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In an electron micrograph, the desmosome appears as a highly organized electron-dense 
structure. The electron-dense nature of the plaque is indicative of negatively-charged polar groups. 
The desmosome consists of 3 main families of proteins: cadherins, armadillo proteins, and plakins . 
The desmosomal cadherins, desmogleins (Dsg) and desmocollins (Dsc), form the transmembrane 
components of the desmosome. In humans and mice, four desmoglein genes (Dsg 1-4) and three 
desmocollin genes (Dsc 1-3) have been identified (Green and Simpson, 2007). These cadherins 
can form homo- or hetero-dimers in a cis- fashion and bind to opposing cadherins in a calcium-
dependent trans- arrangement (Chitaev and Troyanovsky, 1997; Marcozzi et al., 1998; Syed et al., 
2002). Intracellularly, the cadherin tails interact with armadillo proteins, plakoglobin and 
plakophilin (Kowalczyk et al., 1994; Mathur et al., 1994). The armadillo proteins in turn interact 
with plakin family proteins, most notably, desmoplakin (Hatzfeld, 2007; Hatzfeld et al., 2000). 
The plakin proteins tether the desmosome to the underlying cytoskeletal intermediate filaments  
such as keratin (Green et al., 1992; Stappenbeck et al., 1993) (Fig. 1.1). Desmoplakin is a protein 
that is unique to and present in all desmosomes. Studies have revealed a reduction of desmosome 
number and size in desmoplakin knockout models (Gallicano et al., 1998). Therefore, in the current 
study, desmoplakin is used as a proxy to determine the role of desmosomes. 
HUMAN DISEASES OF THE DESMOSOME 
In mammals, desmosomes are predominantly found in various epithelia, the heart, and hair  
follicle. They have been described as rivet-like structures facilitating cell-cell adhesion (Alberts, 
1994). Along with underlying intermediate filaments, this complex also provides mechanica l 
integrity to the skin and heart which are regularly subjected to physical forces (Green et al., 1998; 
Russell et al., 2004). Perturbations of the desmosome and its components have been implicated in 
human disease. Not surprisingly, these diseases have manifestations in the epithelia, the heart, and 
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hair, either separately or in combination (Brooke et al., 2012). Some of the most devastating 
desmosomal diseases are auto-immune. Pemphigus Foliaceus and Pemphigus Vulgaris present 
with acantholysis and blistering of the skin and mucosal membranes, respectively (Payne et al., 
2004). Auto-antibodies are directed against DSG1 in Pemphigus Foliaceus and both DSG1 and 
DSG3 in Pemphigus Vulgaris leading to disease symptoms (Amagai et al., 1991; Ding et al., 1997; 
Ishii et al., 1997). Studies in mice suggest that Pemphigus vulgaris sera may cause endocytosis of 
Dsg3, possibly through steric hindrance, which might contribute to morphological symptoms such 
as the acantholysis observed in Pemphigus vulgaris patients (Amagai et al., 1995b; Calkins et al., 
2006; Jolly et al., 2010; Tsunoda et al., 2003). 
Desmosomal proteins can also be targeted by infectious pathogens. Infectious diseases 
such as Bullous impetigo and its generalized form, Staphylococcal Scalded Skin generally affect 
children under 5 years of age and immunocompromised individuals (Hanakawa et al., 2002; 
Hanakawa et al., 2003; Melish and Glasgow, 1970; Nishifuji et al., 2008). In these diseases, DSG1 
is targeted by the causative Exfoliative toxins (ET), which are glutamate-specific serine proteases 
that cleave DSG1 (Hanakawa et al., 2002; Hanakawa et al., 2003). 
Desmosomal diseases can also be inherited in an autosomal dominant or recessive manner 
(Celentano and Cirillo, 2017; McGrath, 2005). Plakophilin 1 (PKP1) was the first desmosomal 
protein to be linked to hereditary skin disease. Complete loss of PKP1, which is normally found 
in the suprabasal layer, is found to result in ectodermal dysplasia/ skin fragility syndrome 
(McGrath et al., 1997). Autosomal dominant mutations in DSG1 can lead to striate palmoplantar 
keratoderma in the palms of the hand and soles of the feet due to haploinsufficiency (Hunt et al., 
2001; Kljuic et al., 2003b). On the other hand, DSG4 mutations lead to defects in hair follic le 
differentiation with hypotrichosis restricted to scalp, chest, arms, and legs (Kljuic et al., 2003a). 
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The severity of inherited desmosomal diseases is emphasized by the propensity for ventricular 
arrhythmias and sudden cardiac death (Delmar and McKenna, 2010). For instance, plakophilin 2 
mutations are implicated in arrhythmogenic right ventricular cardiomyopathy, a disease which 
accounts for 10% of cardiac-related deaths in teens (Gerull et al., 2004; Thomason et al., 2010; 
van Tintelen et al., 2006).  
Inherited mutations in desmoplakin (DSP) are also diverse, resulting in diseases with 
varying degrees of severity. Autosomal dominant mutations in DSP leading to haploinsufficiency 
result in SPPK, like patients with DSG1 mutations (Armstrong et al., 1999; Whittock et al., 1999). 
These mutations are found in the plakin (N-terminal) domain of DSP. A recessive mutation in 
desmoplakin causes a frameshift in the tail region, perturbing interaction with intermed iate 
filaments (IFs). Patients display dilated cardiomyopathy, woolly hair, and keratoderma – known 
as Carvajal syndrome - and affected individuals experience heart failure within the teens (Carvajal-
Huerta, 1998). Another desmoplakin recessive disease with compound heterozygous mutations 
termed skin fragility ⁄ woolly hair syndrome is reported with similar findings but without the 
dilated cardiomyopathy (Whittock et al., 2002). These cases reveal that desmosomal diseases are 
often associated with symptoms in the epithelia, heart and hair. Additionally, these examples 
highlight the variability in phenotypes when different regions of the same protein are mutated. To 
design effective therapies, it is important to understand how desmosomal components, includ ing 
the various functional domains, contribute to proper development and functioning. 
 
USING ANIMAL MODELS TO STUDY DESMOSOME FUNCTION 
The prevalence of desmosomal diseases and birth defects has prompted the need for animal 
models to understand disease pathology. Currently, the mouse model, Mus musculus, is the most 
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popular in vivo model used to study desmosome function. Desmosomes are first detected in the 
blastocyst stage (32- to 64-cell) in the mouse embryo (Ducibella et al., 1975; Fleming et al., 1991; 
Magnuson et al., 1977). These proteins are expressed after adherens junctions are formed, alluding 
to desmosomes being dispensable during the initial cleavage stages. In the embryos of the teleost 
fishes, Fundulus heteroclitus and zebrafish (Danio rerio), desmosomes begin to appear during 
mid-gastrula stages (~st. 12.5) (Slanchev et al., 2009; Trinkaus and Lentz, 1967). It is possible that 
the relatively late appearance of desmosomes in these fishes might be because of the presence of 
the protective vitelline membrane which may provide structural integrity to the embryo.  
Several mouse models illustrate the important roles of desmosomal proteins during the 
early stages of life (Green and Simpson, 2007). For example, Desmoglein 2 ablation is lethal in 
the mouse embryo, dying shortly after implantation (Eshkind et al., 2002). Similarly, Desmocollin 
3 knockout mice die within the first 2 days of development (Den et al., 2006). Some desmosomal 
components appear to be dispensable in the early embryo (younger than E10) but reveal important 
roles after this stage. For example, plakoglobin knockout mice die by E11 due to cardiac 
abnormalities. Of those that survive until birth, skin fragility is observed (Bierkamp et al., 1996). 
Targeted ablation of Desmoglein 3 in mice leads to runting, hair loss, and suprabasilar acantholys is 
(loss of cohesion) in the epidermis (Koch et al., 1997). Skin defects are also observed in 
Desmocollin 1 knockout mice but acantholysis is instead present in the granular layer in 
conjunction with hyperproliferation (Chidgey et al., 2001). These studies indicate that desmosomal 
proteins have a significant role in the early embryo. 
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DESMOPLAKIN STRUCTURE AND FUNCTION 
In humans and mice, desmoplakin has a tripartite domain structure. The N-terminal plakin 
domain associates with plakoglobin and plakophilin, linking desmoplakin to the desmoso mal 
complex (Al-Jassar et al., 2011; Kowalczyk et al., 1997; Kowalczyk et al., 1999). This domain 
consists of six spectrin repeats and a Src homology domain (SH3) with unrestricted flexibility 
which is believed to impart adaptability to mechanical forces (Al-Jassar et al., 2013; Al-Jassar et 
al., 2011). The rod domain facilitates dimerization of desmoplakin (Green et al., 1990). This 
domain contains a heptad repeat and is thought to form a coiled-coil dimer which interacts with 
intermediate filaments (Garrod and Chidgey, 2008; Green et al., 1990; Green et al., 1992). Finally, 
the C-terminal plakin repeat domain associates with, and is essential for intermediate filament 
attachment (Choi et al., 2002; Green et al., 1990). This C-terminal tail domain contains three 
globular subdomains in H. sapiens desmoplakin, designated A, B and C, each consisting of 4.6 
repeats of a 38-amino acid motif (Green et al., 1990). The periodicity of amino acids in this domain 
allow interaction with intermediate filaments (Bornslaeger et al., 1996; Choi et al., 2002; Fontao 
et al., 2003). Together, these domains are critical to proper functioning of desmoplakin, but they 
have not been analyzed in the X. laevis homologs.  
Several studies in mice have attempted to determine the role of desmoplakin during 
embryonic development. Embryos homozygous for a desmoplakin deletion mutation do not 
survive beyond E6.5 (Gallicano et al., 1998). Most notably, Dsp-/- embryos are significantly 
smaller, although E-cadherin labelling remain unaffected in the developing endoderm and 
ectoderm. Keratin 8 (K8) also appear disorganized within the cell, with a collapse of keratin 
networks to the cell periphery. There is also a >10X reduction in desmosome number and >2X 
reduction in desmosome size. Since the early lethality was suspected to be due to defects in extra-
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embryonic tissues such as the visceral endoderm and the trophectoderm, a tetraploid rescue model 
was developed (Gallicano et al., 2001). Here, the embryo proper that is homozygous for the dsp 
mutation is cultured along with wild-type tetraploid cells, the latter of which eventually develops 
into extra-embryonic tissues (Dragatsis et al., 1998; Kupriyanov and Baribault, 1998). These 
embryos are still significantly smaller with fewer desmosomes. They also have an increased 
lifespan and survive until E12.5. However, the heart is severely deformed with collapsed epicardial 
and myocardial layers. The neuroepithelial folds are also greatly reduced usually preceded by 
defective neural tube closure. Most importantly, the embryonic epidermis displays intercellular 
separation and detachment from the underlying mesoderm. Interestingly, vasculature development 
is also perturbed despite no desmosomes being present normally within these tissues. However, 
desmoplakin is expressed in another junction, the complexus adherents, present in endothelia l 
cells, possibly accounting for this phenotype (Schmelz and Franke, 1993; Schmelz et al., 1994). 
In an effort to understand epidermis-specific roles of desmoplakin, conditional knockout mice 
under the Keratin 14 promoter were also examined. There is no defect in the differentiation of the 
epidermal layers. However ,the epidermis is fragile in these embryos, experiencing intercellular 
separation under an applied mechanical stress (Vasioukhin et al., 2001).  
Desmoplakin has also been implicated in other cellular processes and signaling pathways. 
For instance, desmoplakin can function as a microtubule organizing center in mouse epidermis. 
Ninein, a centrosomal protein required for microtubule anchoring is recruited to the desmosomes 
by Dsp (Delgehyr et al., 2005; Lechler and Fuchs, 2007; Mogensen et al., 2000). There is some 
evidence for the desmoplakin-intermediate filament connection as a regulator of cellular response 
to mechanotransductive signals (Broussard et al., 2017). Although no inherited mutations of 
desmosomal proteins have been found to be oncogenic, downregulation of Dsp can influence 
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tumorigenesis and invasion. Decreased invasion and increased adhesion are observed when 
desmosomal components are introduced into normally non-adhesive fibroblasts (Tselepis et al., 
1998). Dsp-knockdown keratinocytes exhibit increased proliferation associated with increased 
phosphor-ERK1/2 and phosphor-Akt levels (Wan et al., 2007). Furthermore, increased tumor 
invasion is observed in a desmoplakin-deficient mouse model of pancreatic neuroendocrine tumors 
(Chun and Hanahan, 2010). 
 
REGULATION OF THE DESMOSOMAL COMPLEX AND HYPERADHESION 
Embryonic development occurs through the coordination of various processes includ ing 
cell division, migration, intercalation, and cell death. Maintaining tissue adhesion and integr ity 
during morphogenesis would require precise regulation of desmosome dynamics, for example, 
through control of transcription and post-translational modifications. Transcription factors 
associated with regulation of desmosomal gene expression include AP-2, Oct-2, NF-kB, Lef-1, 
HoxC, and C/EBP (Adams et al., 1998; Bazzi et al., 2009; Johnson et al., 2014; Marsden et al., 
1997; Potter et al., 2001). Protein Kinase C alpha (PKCα), EGFR, lipid raft clusters, and 
plakophilins are documented as regulators of desmosomal assembly and adhesive strength (Bass-
Zubek et al., 2008; Garrod et al., 2005; Kimura et al., 2007; Klessner et al., 2009; Miravet et al., 
2003; Stahley et al., 2014; Tucker et al., 2014; Wallis et al., 2000; Yin et al., 2005). Furthermore, 
desmosomal components can regulate signaling pathways. For example, plakoglobin can regulate 
Wnt/ β-catenin (Chidgey and Dawson, 2007; Conacci-Sorrell et al., 2002; Miravet et al., 2002), 
p38MAPK (Spindler et al., 2014), and Hippo signaling (Chen et al., 2014). Recent studies also 
suggest regulation of biochemical and mechanotransductive signaling by desmoplakin (Broussard 
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et al., 2017; Yang et al., 2012). However, not much is known about the downstream effectors of 
these signaling pathways. 
Cadherins in both adherens junctions and desmosomes require calcium for homophil ic 
binding and maintenance of adhesion at cell contacts. However, desmosomes have a unique 
property of achieving insensitivity to calcium chelators (such as EGTA) when they mature and are 
termed “hyperadhesive” (Garrod and Kimura, 2008). Cells with calcium-insensitive desmosomes 
are in a stronger adhesive state (Kimura et al., 2007). Molecular modeling of the crystal structure 
of the EC domains of desmosomal cadherins suggests that the Ca2+ ion is trapped, making it 
isolated from calcium chelators (Garrod et al., 2005). Hyperadhesive desmosomes are thought to 
identified by the presence of an electron-dense midline between apposing desmosome halves under 
electron microscopy, although direct evidence is yet to be demonstrated.  
Hyperadhesive desmosomes were first detected in the stratified epithelia of the Rana 
pipiens (frog) adult skin and cat and rat esophagi as being resistant to EDTA-mediated dissociation 
(Borysenko and Revel, 1973). In keratinocyte and simple epithelial cell culture, desmosomes begin 
to assemble when calcium (1.8 - 2mM) is added to the growth medium in as soon as 15 min. 
(Mattey and Garrod, 1986; Watt et al., 1984). The addition of calcium is also followed by 
stratification of the monolayer within 24h. Only when confluency is reached are desmosomes 
demonstrated to achieve hyperadhesion (Wallis et al., 2000). Hyperadhesive desmosomes are also 
found in the developing mouse embryo. For instance, the first epidermal desmosomes that 
assemble are sensitive to disruption by calcium chelation but switch to a hyperadhesive nature 
between E12.0-14.0 (Kimura et al., 2012).  
There are many mechanisms found to regulate the adhesive state of the desmosome. Since 
wound healing is a dynamic process requiring some cell movements, it is not surprising that 
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desmosomes need to switch from their hyperadhesive state upon wounding. Wallis and colleagues 
observed the switch to a calcium-sensitive state upon scratch wounding of monolayers (Wallis et 
al., 2000). Importantly, Protein Kinase C α (PKCα) activation is increased after wounding and is 
thought to be responsible for the switch from a resistant to calcium-sensitive state. Plakophilin 1 
overexpression in keratinocytes transforms desmosomes to a hyperadhesive state (Tucker et al., 
2014). Since it is known that Dsp-IF interaction is crucial for maintaining adhesive strength in 
epithelial sheets, the function of Dsp in hyperadhesion was also explored (Huen et al., 2002). A 
phosphorylation-deficient mutant of Dsp (S2849G) with increased IF binding leads to increased 
cohesiveness of cell sheets (Hobbs and Green, 2012). Importantly, being able to modulate the 
adhesive state of the desmosome might be an effective therapeutic strategy for some desmosomal 
diseases. Overexpression of Plakophilin 1 or PKC inhibition in keratinocytes induces 
hyperadhesion and abrogates Pemphigus vulgaris sera-induced loss of adhesion (Cirillo et al., 
2010; Tucker et al., 2014). Therefore, being able to identify regulators of desmosomes is benefic ia l 
to alleviate the pathophysiology of certain desmosomal diseases.  
 
C-JUN N-TERMINAL KINASE 
The c-Jun N-terminal kinase or JNK, also known as stress-activated MAP kinase (SAPK) 
is a member of MAPK signaling pathways through which cells respond to extracellular stimuli. 
These stimuli can include UV radiation, pH fluctuations, and heat, as well as chemical stimula t ion 
including cytokines, growth factors, and hormones (Davis, 2000; Weston and Davis, 2002). 
The MAPK signaling cascade contains at least three MAP kinases in series. MAPKKKs 
phosphorylate MAPKKs, which phosphorylate MAPKs such as JNK. JNK is activated by dual 
phosphorylation on Threonine and Tyrosine residues by MKK4 and MKK7 (Davis, 2000; Derijard 
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et al., 1995; Lin et al., 1995; Moriguchi et al., 1997; Tournier et al., 1997; Yan et al., 1994). MKK4 
and MKK7 are known to be activated by ASK1, MLK2, and MEKK2-5 (Blank et al., 1996; Deacon 
and Blank, 1997; Ellinger-Ziegelbauer et al., 1997; Gerwins et al., 1997; Hirai et al., 1997; Ichijo 
et al., 1997). However, all these proteins can be differentially regulated. For example, treatment of 
cells with tumor necrosis factor (TNF) leads to activation of MKK7 but not MKK4 (Takekawa et 
al., 1997; Tournier et al., 2001; Wang et al., 1996). In contrast, both MKK4 and MKK7 can be 
activated by environmental stresses. The JNK signaling cascade is thought to be coordinated, in 
part, by JNK interacting proteins (JIP) that act as scaffolds for JNK cascade elements (Gupta et 
al., 1996; Kukekov et al., 2006; Xu et al., 2005). 
JNK regulates activator protein-1 (AP-1) transcriptional activity through the 
phosphorylation of various effectors. For example, JNK phosphorylates the transactivation domain 
of c-Jun on Ser-63 and Ser-73 leading to its stabilization and increased transcriptional activity 
(Pulverer et al., 1991; Smeal et al., 1991). JNK can also phosphorylate other transcription factors 
including Junb, JunD, c-Fos, and ATF2 (Ip and Davis, 1998). Together, these proteins constitute 
the AP-1 transcription factors that regulate stress-responsive genes. 
Some of the major effects of the JNK pathway are inflammatory responses and regulat ion 
of apoptosis and cell survival. JNK can mediate opposing responses through isoform- or cell-
specific mechanisms. For example, JNK1 and JNK2 differentially affect fibroblast prolifera t ion 
through either promoting or reducing c-Jun stability (Sabapathy et al., 2004). JNK can also have 
opposite effects on apoptosis, either promoting it by phosphorylating Bim and Bmf, or suppressing 
it through its effects on Bcl-2 and Bcl-xL (Donovan et al., 2002; Ferrer et al., 2005; Kharbanda et 
al., 2000; Lei and Davis, 2003; Yamamoto et al., 1999). 
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In mammals, there are three JNK genes, JNK1, JNK2, and JNK3, all of which can undergo 
differential splicing, resulting in a total of 10 isoforms. JNK1 and JNK2 are expressed 
ubiquitously, while JNK3 is largely restricted the brain, heart, and testis (Bogoyevitch and Kobe, 
2006; Davis, 2000). Xenopus is also predicted to have all 3 JNK genes, but there is limited 
expression data at the tissue level (Bagowski et al., 2001). In situ hybridization reveals expression 
of JNK1 in head and dorsal regions of the Xenopus embryo after neurulation (Garriock et al., 2005; 
Yamanaka et al., 2002). Several animal models reveal the importance of JNK in vivo during 
embryogenesis. Single knockout Jnk1-/- and Jnk2-/- mice are viable, with defects in apoptotic and 
immune responses (Constant et al., 2000; Dong et al., 2000; Dong et al., 1998; Tournier et al., 
2000). However, Jnk1-/-/Jnk2-/- double knockout mice exhibit embryonic lethality with decreased 
apoptosis in the hindbrain, increased apoptosis in the forebrain, and exencephaly (Kuan et al., 
1999; Sabapathy et al., 1999).  
JNK is also known to regulate embryonic morphogenesis in vivo. In D. melanogaster, JNK 
activity positively regulates dorsal closure through DJun and expression of decapentaplegic 
(related to mammalian BMP-4) in leading edge cells of the dorsal epidermis (Glise and Noselli, 
1997; Hou et al., 1997; Kockel et al., 1997; Riesgo-Escovar and Hafen, 1997; Sluss and Davis, 
1997). In Xenopus embryos, both activation and inhibition of JNK can lead to convergent 
extension defects (Yamanaka et al., 2002). JNK isoforms are also important for proper 
development of the epidermis in vivo. For example, JNK1-deficient mice exhibit reduced 
epidermal proliferation and differentiation resulting in a thinner epidermis. However, mice 
deficient in JNK2 have epidermal hyperplasia, suggesting opposite roles for JNK1 and JNK2 in 
epidermal development (Weston et al., 2004). 
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JNK activity is dysregulated in a variety of human diseases affecting many organs. Strong 
JNK activity has been observed in neurons and the hippocampus in patients with Alzheimer’s 
disease (Shoji et al., 2000; Thakur et al., 2007; Zhu et al., 2001). Furthermore, liver samples from 
patients with nonalcoholic fatty liver disease are found to have elevated JNK activity (Ferreira et 
al., 2011). Unsurprisingly, JNK activity is also elevated in diseases with abnormal inflammatory 
responses including inflammatory bowel disease and rheumatoid arthritis (Mitsuyama et al., 2006; 
Mun et al., 2009; Schett et al., 2000). Similarly, JNK is activated in psoriatic skin, probably leading 
to abnormal epidermal proliferation and differentiation (Takahashi et al., 2002). Besides these 
instances, many cancers including retinoblastoma, melanoma nevi, and colorectal, breast, and 
ovarian cancers, exhibit altered JNK activity (Chen et al., 2011; Gulmann et al., 2009; Jorgensen 
et al., 2006; Odegaard et al., 2007; Wang et al., 2010). Therefore, understanding the role of JNK 
in mediating cellular processes will facilitate the development of therapeutic strategies. 
 
SIGNIFICANCE 
Work in the past decade has delineated novel functions of desmosomes in both adhesive 
and nonadhesive contexts. However, in the context of the whole embryo, much is unknown 
regarding regulation and function of the desmosomal complex during morphogenesis. The present 
study reveals roles for desmosomes in epidermal homeostasis and morphogenesis. Furthermore c-
Jun N-terminal kinase (JNK) may have a potential role in regulation of desmosome assembly and 
stability. Notably, this study validates the frog as a tractable vertebrate model to study desmosome 
regulation and function in the developing embryo. 
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Figure 1.1: The desmosome and its components. 
Schematic of a desmosome (adapted from (Garrod, 2010; Green and Simpson, 2007; Staehelin and 
Hull, 1978; Stahley and Kowalczyk, 2015)). EC=Extracellular space; IC=Intracellular space; 
Dsg=Desmoglein; Dsc=Desmocollin; Dsp=Desmoplakin; Pg=Plakoglobin; Pkp=Plakophilin; 
IF=Intermediate Filament. 
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MATERIALS AND METHODS 
 
 
A. XENOPUS ADULTS AND EMBRYOS 
Xenopus laevis embryos were obtained and cultured using standard methods (Sive et al., 
2000) approved by the VCU Institutional Animal Care and Use Committee (IACUC protocol 
number 5AD20261). Embryos were staged according to Nieuwkoop and Faber (Nieuwkoop and 
Faber, 1967). 
 
B. BIOINFORMATICS ANALYSIS TO COMPARE DESMOPLAKIN EXONIC 
SEQUENCES 
The following full length desmoplakin exonic sequences of the longest isoforms were 
retrieved from NCBI: Homo sapiens Desmoplakin isoform I (NM_004415.3) and Mus musculus 
Desmoplakin (NM_023842.2). Xenopus laevis exonic sequences for dsp.L (XB-GENE-866134) 
and dsp.S (XB-GENE-17346609) were both obtained from Xenbase (http://www.xenbase.org). To 
estimate percent identity, pairwise sequence alignments were performed against X. laevis dsp.L 
using the EMBOSS Water tool (Smith Waterman algorithm) (https://www.ebi.ac.uk/) and 
DNAfull scoring matrix  (Li et al., 2015; McWilliam et al., 2013; Rice et al., 2000). 
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C. BIOINFORMATICS ANALYSIS TO COMPARE DESMOPLAKIN PROTEIN 
SEQUENCES 
The following full length Desmoplakin (Dsp) protein sequences of the longest isoforms 
were retrieved from NCBI: Homo sapiens Desmoplakin I (NP_004406) and Mus musculus 
Desmoplakin (NP_076331) were used for the analysis. To obtain Xenopus laevis Dsp.L (XB-
GENE-866134) and X. laevis Dsp.S (XB-GENE-17346609) protein sequences, coding DNA 
sequences obtained from Xenbase Genome build Version 9.1 (X. laevis) (http://www.xenbase.org) 
were translated using the ExPASy Translate tool (Gasteiger et al., 2003). To obtain percent identity 
and similarity, pairwise sequence alignments were performed against X. laevis Dsp.L using the 
EMBOSS Water tool (Smith Waterman algorithm) (EMBL-EBI) with the BLOSUM62 scoring 
matrix (Li et al., 2015; McWilliam et al., 2013; Rice et al., 2000). 
 
D. DETERMINING DESMOPLAKIN DOMAINS IN XENOPUS LAEVIS 
To determine coordinates of domains, previously characterized domain coordinates in 
human DSPI protein was used as a reference (Al-Jassar et al., 2011; Green et al., 1990; Virata et 
al., 1992). The LALIGN tool (EMBL-EBI) was used to align the amino acid sequence for each 
human DSP domain with the full- length protein of M. musculus Dsp and X. laevis Dsp.L and Dsp.S 
to locate the corresponding regions (Li et al., 2015; McWilliam et al., 2013). This was done using 
the BLOSUM50 scoring matrix. To obtain percent identity and similarity for each domain, 
pairwise sequence alignments were performed against corresponding domains in X. laevis Dsp.L. 
The EMBOSS Water tool (Smith Waterman algorithm) (EMBL-EBI) was used with the 
BLOSUM62 scoring matrix (Li et al., 2015; McWilliam et al., 2013; Rice et al., 2000). 
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E. MULTIPLE SEQUENCE ALIGNMENT OF DESMOPLAKIN PROTEIN 
Multiple sequence alignment of desmoplakin protein sequences of X. laevis (Dsp.L and 
Dsp.S), human, and mouse was performed with Clustal Omega (EMBL-EBI) using the HHalign 
algorithm (Goujon et al., 2010; McWilliam et al., 2013; Sievers et al., 2011). The threshold for 
shading (using the BOXSHADE tool) in the Clustal Omega generated sequence alignment was set 
to 50% using the BLOSUM62 scoring matrix. 
 
F. TEM TO EXAMINE DESMOSOME ULTRASTRUCTURE AND 
LOCALIZATION IN THE EPIDERMIS 
Embryos were fixed with 2% glutaraldehyde (MP Biomedicals, 198595) in 0.1M sodium 
cacodylate buffer (Electron Microscopy Services, 12300) at 4°C overnight. They were then rinsed 
in 0.1M cacodylate buffer three times (30 min. each). Embryos were incubated in 0.1M cacodylate 
buffer for up to 3 days at 4°C and then fixed in 2% osmium tetroxide in 0.1M cacodylate buffer 
for one hour. They were then rinsed in 0.1M cacodylate buffer three times (15 min. each). They 
were dehydrated in graded ethanol series (50%, 70%, 80%, 95%) for 5-10 minutes each followed 
by dehydration in 100% ethanol three times (10-15 min. each). Embryos were then incubated in 
propylene oxide (EMS, 20401) three times (10–15 min. each). They were then infiltrated with a 
50/50 mix of propylene oxide and Poly/Bed 812 resin mix (Polysciences, 08792-1) overnight. This 
was followed by infiltration with pure EMbed 812 resin (EMS, 14120)  mix overnight. Embryos 
were then embedded in flat molds and placed in 60˚C oven for 2 days. Embryos were sectioned on 
Leica EM UC6i Ultramicrotome (Leica Microsystems) into 700-900Å thick sections on grids and 
stained with 5% Uranyl acetate (EMS, 22400) and Reynold’s Lead Citrate (Lead Nitrate (EMS, 
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17900), Sodium Citrate (EMS, 21140)). Grids were imaged on JEOL JEM-1230 TEM  (JEOL 
USA, Inc.) with the Gatan Orius SC1000 digital camera (Gatan Inc., Pleasanton, CA). 
 
G. MORPHOLINOS 
Two splice-site blocking desmoplakin (Dsp) morpholinos, DspMO1 (5’-
ACAGTTACTACTTACTCTATGCTGC-3’) and DspMO2 (5’–
TTGATGCAGAGCAAAGTTCAAACCT-3’) with fluorescein tags were designed and purchased 
from Genetools (Table 1.1).  A standard control morpholino (CMO) provided by Genetools was 
used as a control for all experiments. 34 ng of DspMO1 was injected per embryo and 17-25ng 
DspMO2 was injected per embryo. Targeted injections were accomplished with 3-5 ng per 
blastomere.  Microinjections were carried out using a FemtoJet microinjector (Eppendorf) and a 
SteREO Discovery.V8 (Zeiss) stereoscope. 
To determine if the MOs caused splicing defects in embryos, RT-PCR was performed as 
described previously (Dickinson and Sive, 2009). RNA from 10 embryos  was extracted using 
TRIzol  (Invitrogen) followed by lithium chloride precipitation. cDNA was prepared using the 
High-capacity cDNA Reverse Transcription kit and specific primers (Applied Biosystems) (Table  
1.2). cDNA was then diluted 1:25 and the following PCR program was performed using Apex™ 
Hot Start Taq DNA Polymerase Master Mix: (1) 95°C for 5 min., (2) (95°C for 30s, 61°C for 30s, 
72°C for 30s) X 40, (3) 72°C for 5 min. Samples were run on a 3% agarose gel to identify distinct 
banding patterns. 
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H. CRISPR 
CRISPR gRNA sequences were designed against exons 8 (DspCRISPR1) and 19 
(DspCRISPR2) in dsp.L (these correspond to exons 8 and 17 in dsp.S, respectively) using the 
CHOPCHOP tool (http://chopchop.cbu.uib.no/). sgRNA adaptor sequences and scaffold (loop-
sequence oligo) were designed as previously described (Shah et al., 2016) (Table 1.3).   
The PCR reaction to create a 120 bp product containing gene-specific sequence, T7 primer 
sequence and loop-specific oligo was as follows: (1) 98°C for 30s, (2) (98°C for 10s, 61°C for 10s, 
72°C for 15s) X 45, (3) 72°C for 5 min. The PCR product was then purified using the DNA Clean 
& Concentrator Kit (Zymo Research, D4014). The Ambion MEGAscript T7 kit (Thermo Fisher 
Scientific, AM1333) was used for in vitro transcription and RNA was preferentially precipitated 
using the lithium chloride precipitation solution (Thermo Fisher Scientific, AM9480). To create 
F0 mosaic mutants, embryos were co-injected with 1ng gRNA and 1.5ng Cas9 protein (PNA-Bio, 
CP01) at the one-cell stage. Wild-type embryos were used as controls.  
The T7 endonuclease I assay was used to detect mutations induced by CRISPR/ Cas9 
(Mashal et al., 1995). Genomic DNA was extracted by incubating embryos in 35μl of alkaline lysis 
buffer (25 mM NaOH (Fisher Scientific, BP359), 0.2 mM Na2+-EDTA (OmniPur, 4050)) at 95°C 
for 40 minutes. The samples were then cooled to 4°C and then 35μl of neutralization buffer (40 
mM Tris-HCl (Sigma-Aldrich, T3253)) was added.  The target region was then amplified with 
specific primers (Table 1.4). The PCR reaction was: 1. 98°C for 30s, 2. (98°C for 5s, 61°C for 
10s, 72°C for 20s) X 36, 3. 72°C for 2min. PCR products were purified with the DNA Clean and 
Concentrator kit (Zymo Research, D4014), eluted into nuclease-free water, and quantified using 
the NanoDrop Lite spectrophotometer (Thermo Fisher Scientific). Purified PCR product (200ng) 
was used in the following protocol:  1. 95°C for 5 min., 2. 95°C-85°C @ -2°C/s, 3. 85°C-25°C @ 
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-0.1°C/s. Then, 1μl of T7 endonuclease I (NEB, M0302) was added and incubated at 37°C for 15 
min. Samples were run on a 3% agarose gel to identify presence of mutations. 
 
I. MECHANICAL STRESS ASSAYS 
Impact Assay: Embryos were vertically dropped from a height of 15 cm using a transfer 
pipette (Fisher Scientific, 13-711-7M) onto a 150 X 15mm petri dish lined on the bottom with 
5mm of 2% agarose (Bioline, 41025). Images were taken on both left and right lateral sides of the 
embryos before and after the assay was performed. This was replicated in a blind manner to avoid 
any handling bias while pipetting embryos. Differences were compared statistically using a 
Student’s t-test. 
Rotational Assay: Embryos were placed in 50ml plastic polypropylene tubes (USA 
Scientific, 1500-1811) with 15 ml 0.1 X MBS (Modified Barth’s Saline). The tubes were then 
rotated using a RKVSD vertical rotating mixer (ATR Biotech) at 55 rpm for a total of 25 rotations. 
Embryos were then scored as being intact or damaged based on whether the epidermis was intact 
or not. Differences were compared statistically using a Student’s t-test. 
 
J. CONSTITUTIVELY-ACTIVE JNK AND DOMINANT-NEGATIVE 
DESMOPLAKIN 
The previously validated constitutively-active JNK1, MKK7-JNK1A1 (pcDNA3-
flagMKK7B2Jnk1a1) (referred here as CA-JNK) construct was obtained from Addgene (ID: 
19726) (courtesy of Roger Davis) and cloned into pCS2+ for expression in X. laevis embryos 
(Houssin et al., 2017). The dominant-negative desmoplakin (DP-NTP) construct fused with either 
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EGFP or mCherry (in pCS2+) was generously provided by Dr. Daniel Conway (Bornslaeger et al., 
1996; Huen et al., 2002).  
 
K. CHEMICAL TREATMENTS 
To inhibit JNK, embryos were treated with 100µM SP600125 (Sigma-Aldrich, S5567) 
(Bennett et al., 2001). DMSO was used as the control treatment at a final concentration of 1% in 
0.1X MBS. 
 
L. IMMUNOFLUORESCENCE, ANTIBODIES AND FLUORESCENT LABELING 
Embryos were fixed in 4% Paraformaldehyde (PFA) or Dent’s fixative (80% methanol, 
20% DMSO) and then labeled whole or after vibratome sectioning. For sectioning, embryos were 
embedded in 5% low-melt agarose (SeaPlaque GTG Cambrex) and sectioned using a 5000 Series 
Vibratome into 150-200µm sections. All antibodies were diluted in 1X PBT. Primary antibodies 
used were mouse anti-desmoplakin I+II (abcam, ab16434, diluted 1:75), mouse anti α-tubulin 
(Developmental Studies Hybridoma Bank (DSHB), AA4.3, 1:50), rabbit anti-phospho-Histone H3 
(Ser10) (Millipore, 06-570, 1:1000), mouse anti-cytokeratin type II (DSHB, 1h5, 1:25), anti-β-
catenin (Invitrogen, 71-2700, 1:500), and mouse anti-E-cadherin extracellular domain (DSHB, 
5D3, 1:25). Secondary antibodies used were anti-mouse Alexa Fluor 568 (Molecular Probes, 
A11004, 1:500), anti-rabbit Alexa Fluor 488 (Molecular Probes, A11008, 1:500), anti-mouse 
Alexa Fluor 488 (Molecular Probes, A11029, 1:500), anti-rabbit Alexa Fluor 568 (Molecular 
Probes, A11036, 1:500), anti-mouse Alexa Fluor Plus 647 (Molecular Probes, A32728, 1:500) and 
anti-rabbit Alexa Fluor 405 (Molecular Probes, A31556, 1:500). To  label small secretory cells, a 
Lectin PNA-Alexa Fluor 488 conjugate (Molecular Probes, L21409, 1:1000) was utilized. 
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Rhodamine phalloidin (Life Technologies, R415, 1:50) was used to label F-actin. Embryos fixed 
in PFA were washed three times in 1X PBT (1h each). Embryos fixed in Dent’s fix were incubated 
in 90% MeOH for 10 min., then in 100% MeOH for 10 min. They were then stored at -20°C 
overnight in 100% MeOH. Embryos were then incubated in a MeOH: PBT (1X) dilution series 
into 1X PBT. Embryos (fixed in either PFA or Dent’s fix) were then incubated in the primary 
antibody or fluorescent label at 4°C overnight. They were then washed three times in 1X PBT (1h 
each) and incubated in secondary antibody at 4°C overnight. This was repeated for multiple labels. 
Embryos were then washed three times in 1X PBT (1h each) and were mounted in 90-100% 
glycerol for confocal imaging.  
For Cleaved Caspase-3 labeling (anti-rabbit, Cell Signaling, 9661, 1:1000), embryos were 
fixed in 4% PFA (2-3h at RT), embryos and then were washed in PBT and blocked in 1% goat 
serum/ 1% Triton PBT overnight (Kennedy and Dickinson, 2012). They were incubated in 
antibody on a nutating mixer at 4°C for 2 days.  
 
M. CONFOCAL MICROSCOPY 
Imaging was performed with the Nikon Eclipse Ni-U/ C2 confocal microscope. Step size 
was maintained at 0.5μm and size of stack was set between 6-12μm. Finally, maximum intens ity 
projections of these stacks were obtained. The NIS-Elements AR 4.50.00 software was used for 
imaging and processing, including increasing intensity of images where allowed. Additional image 
processing was performed in Adobe Photoshop Creative Cloud. Brightness of images was 
increased or decreased to the same level in all images in an experiment. 
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N. ANALYSIS OF KERATIN RETRACTION IN DSP MORPHANTS 
To determine the effect of morpholino-mediated loss of Dsp on keratin organizat ion, 
additional image analysis was performed using the NIS-Elements AR 4.50.00 software. Maximum 
intensity projections of confocal images on Keratin-labeled embryos was generated. Using 
information from an Intensity Profile chart in a linear cross-section, intensity values were obtained 
for membrane junctions on opposite sides of a cell. These Border Intensity values (BI) were 
averaged (AvgBI).  The coordinates of the 2 borders where intensity was recorded were also noted. 
Three equidistant points between the two border coordinates above were placed within the cell on 
the same linear cross-section. Intensity values were calculated at these three points also. These 
Intracellular Intensity values (ICI) were averaged (AvgICI). A ratio of (AvgBI/AvgICI) was obtained 
for eight random cells in an image (representative of one embryo). Statistical analysis of 
differences between intensity ratios of Dsp morphants and control morphants was performed using 
a Student’s t-test. 
 
O. BIOTIN LABELING OF THE SUPERFICIAL LAYER 
Embryos were incubated from st. 19 (21hpf) to st. 20 (22hpf) in a 2mg/ml solution of EZ-
Link Sulfo-NHS-LC-Biotin for 1h (Thermo Fisher Scientific, 21335). Embryos were then 
transferred to 0.1X MBS to develop for another 4-5h until st. 24 (26hpf). Embryos were then fixed 
in 4% PFA overnight at 4°C. Embryos were then washed three times in 1X PBT for 1h each and 
blocked with 1%BSA at RT for 1h. Embryos were labeled with Streptavidin, conjugated to Alexa 
Fluor 568 (Life Technologies, S11226, 1:500) overnight followed by three washes in 1X PBT for 
30 min. each. They were mounted in 90% glycerol and imaged using a confocal microscope. 
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P. SURFACE AREA MEASUREMENT OF INTERCALATED CELLS 
To measure the surface area of intercalated cells, confocal images were processed in Adobe 
Photoshop CC 2017. Under Image Adjustments, threshold was set such that intercalated cells were 
visible as distinct cells from the biotin- labeled cells. A scale bar was calibrated for each image. 
Using the Magic Wand Tool, individual cells were automatically selected and areas were 
calculated. These measurements were exported to Microsoft Excel and statistical analysis was 
performed.  
 
Q. EGTA-INDUCED CELL DISSOCIATION 
Embryos were treated with either 100μM SP600125 (20μl of 10mM stock in DMSO) or 
20μl DMSO in 0.1 X MBS at 15°C from st. 32–41. DMSO was used as the control treatment at a 
final concentration of 1%. Whole embryos were washed for 1 hour in calcium-free 0.1 X MBS. 
This was followed by a 4mM EGTA treatment for 30 min. Embryos were then fixed in Dent’s fix, 
labeled for desmoplakin and imaged as described above. 
 
R. STATISTICAL ANALYSIS 
Chi-square (χ2) test for independence was used to determine statistically significant 
differences in phenotype prevalence. Pooled data from replicates was used for length and 
phenotype analysis. Mann-Whitney test (GraphPad Prism) was used to determine statistica l ly 
significant differences in surface areas of intercalating cells. Student’s t-test was used to determine 
statistical significance in the remaining comparisons. All data is representative of at least two 
independent experiments. 
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Table 1.1: Morpholino sequences used for injections. 
Morpholino Sequence (5’ –> 3’) Subgenome 
Homolog 
Exon/ 
Intron 
junction 
Match with 
target site  
(bp/ bp) 
DspMO1 
ACAGTTACTACTTACTCTAT
GCTGC 
dsp.L E4/ I4 25/ 25 
dsp.S E4/ I4 19/ 25 
DspMO2 
TTGATGCAGAGCAAAGTTC
AAACCT 
dsp.L E14/ I14 25/ 25 
dsp.S E12/ I12 22/ 25 
 
Table 1.2: Primers used to genotype morphants. 
Morpholino Forward Primer (5’ –> 3’) Reverse Primer (5’ –> 3’) Wild-type 
fragment 
size (bp) 
DspMO1 
TAAATATGGAGATGCAAG
TCAGC 
CAAGATCCCATCGATAG
TCAGC 
422 
DspMO2 
CCTGGCACTACTGCATGAT
C 
AACAGCCAGTTCTCTTGT
TTCTC 
388 
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Table 1.3: CRISPR gRNA sequences and mismatches. 
gRNA gRNA sequence + 
PAM  
(5’ –> 3’) 
Subgenome 
Homolog 
Exon Target site with mismatches (in 
BOLD)  
(5’ –> 3’)  
DspCRISPR1 
GGTGCTGGTTC
ATGATAAGCTG
G 
dsp.L 8 GGTGCTGGTTCATGATAAGC 
dsp.S 8 GGTGCTGGTTCATGATAAGC 
DspCRISPR2 
GGTCGCATCTG
ACAGTTTGATG
G 
dsp.L 19 GGTCGCATCTGACAGTTTGA 
dsp.S 17 GATCGCATCTGACAGTTTGA 
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Table 1.4: Primers for CRISPR mutation analysis with T7 endonuclease I assay. 
gRNA Primers Primer sequence (5’ –> 3’) Wild-
type 
fragment 
size (bp) 
Approx. 
fragment 
sizes if 
cleaved 
(bp) 
DspCRISPR1 
dsp.L 
Forward 
AAACTGATGAGTGAGCTGGAG 237 68, 169 
dsp.L 
Reverse 
CTTGACAAGACCACTAAACCC 
dsp.S 
Forward 
AAACTGATGAGTGAGCTGGAG 380 68, 312 
dsp.S 
Reverse 
ATTTTCTTTCAGGTGGACATCG 
DspCRISPR2 
dsp.L 
Forward 
GGGAATTAGAGAAACAAAGCAAGC 382 111, 271 
dsp.L 
Reverse 
GCATTTTCTACCAGTGGCTG 
dsp.S 
Forward 
GTGGGAATTAGAGAAGCAAAGC 325 113, 212 
dsp.S 
Reverse 
ACCTTTGCTATGTGTGTAGGG 
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RESULTS 
SECTION 1: DEVELOPMENT AND STRUCTURE OF THE EMBRYONIC 
DESMOSOME IN XENOPUS LAEVIS 
  
Although the desmosomal structure has been reported in Xenopus laevis adult and tadpoles 
(Borysenko and Revel, 1973), it has not been examined at earlier developmental stages. Further, 
studies of the desmosomal complex in Xenopus have widely focused on plakoglobin but not other 
crucial desmosomal proteins (DeMarais and Moon, 1992; Karnovsky and Klymkowsky, 1995; 
Kofron et al., 2002; Kofron et al., 1997). Therefore, the goal of this section is to determine if and 
when desmosomes and desmoplakin, a critical desmosomal protein, are present in the X. laevis 
embryo. 
 
A. TEM ANALYSIS OF DESMOSOMES REVEALED CONSERVED 
ULTRASTRUCTURE AND INCREASING NUMBERS DURING 
DEVELOPMENT 
While others have demonstrated that desmosomes exist in the adult and tadpole epidermis 
of X. laevis (Borysenko and Revel, 1973), these structures have not been identified in the early 
embryo. Therefore, to fill this gap in knowledge, desmosomes were imaged by Transmiss ion 
Electron Microscopy (TEM) as the embryo develops through gastrulation and neural tube 
formation. Ultrastructurally, the desmosome appeared as an electron-dense cytoplasmic plaque 
that was present adjacent to the plasma membrane of opposing cells (Fig. 1.2A).  In a subset of 
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desmosomes, a midline in the extracellular space between plaques in opposing cells was present. 
This structure is thought to signify stable trans-interactions between the desmosomal cadherins 
(Fig. 1.2B). These results indicate that in the early embryo of X. laevis, desmosomes resembled 
those observed in M. musculus, D. rerio, as well as adult amphibians, signifying a conserved 
ultrastructure (Borysenko and Revel, 1973; Fleming et al., 1991; Garrod and Chidgey, 2008; 
Goonesinghe et al., 2012). 
The number of desmosomes per junction have been reported to increase during human 
development (Dale et al., 1985; Holbrook and Odland, 1975). Therefore, to determine if Xenopus 
embryos exhibited a similar increase, desmosomes were counted in the outer ectodermal layer in 
various stages ranging from st. 10 to st. 22. These stages were chosen because they represent a 
critical period of ectodermal development. During  this time, the ectoderm forms, undergoes 
migratory movements to envelop the whole embryo (Nieuwkoop and Faber, 1967), and begins to 
express early epidermal differentiation markers (Jonas et al., 1985; Wilson and Hemmati-
Brivanlou, 1995). Therefore, desmosomes were counted at st. 10 (9-11 hpf), st. 14 (16-17 hpf), st. 
19 (21-22 hpf) and st. 22 (24-25 hpf) (n=2 embryos/ stage). At st. 10 (9-11 hpf), tight junctions 
and adherens junctions were observed at the apical-most region of all cell-cell junctions (green bar, 
Fig. 1.2C).  However, desmosomes were only observed in 28% of these junctions (yellow arrow, 
Fig. 1.2C, D). Further, only one desmosome was observed at each of these junctions (Table 1.5). 
At st. 14 (16-17 hpf), desmosomes were detected at 51% of junctions (yellow arrow, Fig. 1.2E, F; 
Table 1.5). At st. 19 (21-22 hpf), desmosomes were detected in 76% of junctions (yellow arrows, 
Fig. 1.2G, H). While 68% of these junctions had one desmosome, two desmosomes were observed 
in 8% of junctions (Table 1.5). At st. 22 (24-25 hpf), desmosomes were observed in 93% of 
intercellular junctions (yellow arrows, Fig. 1.2I, J). At this time, more than half of all junctions 
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had more than one desmosome. Specifically, 47% of junctions had two desmosomes and 9% of 
junctions had three or more desmosomes (Table 1.5). These results indicate that the number of 
desmosomes increase during early development of the X. laevis embryo, consistent with 
observations in the developing human embryo. 
Thus far, the TEM analysis was only focused on desmosomes in the outer layer of the 
ectoderm. The Xenopus embryonic ectoderm and epidermis are bi-layered (Itoh et al., 1988; 
Nieuwkoop and Faber, 1967). Therefore, the next step was to determine whether desmosomes 
could also be detected in the inner epidermal layer. At st. 31 (37-40 hpf), in a subset of images, 
desmosomes were visible between cells of the inner epidermal layer (red arrow, Fig. 1.2L). At st. 
44 (92-98 hpf), desmosomes were also present between the outer and inner epidermal layers (green 
and red arrows, Fig. 1.2M). The inner epidermal layer was not examined before st. 31. These 
results indicate that desmosomes are present between cells of both epidermal layers of the X. laevis 
embryo. 
 
B. COMPARATIVE SEQUENCE ANALYSIS OF X. LAEVIS DESMOPLAKIN 
WITH OTHER VERTEBRATES REVEALED CONSERVED DOMAINS 
A comparative sequence analysis of the intracellular desmosomal protein, desmoplakin 
(Dsp), has not been performed between X. laevis and mammalian homologs.  Such an analysis 
provides a measure of sequence identity and similarity between homologs in different species and 
can be used to predict whether its function is shared. Therefore, a bioinformatics analysis was 
performed to 1) determine overall gene and protein sequence similarity with homologs of other 
vertebrate species, 2) identify the key functional domains of X. laevis Dsp, and 3) determine 
sequence similarity between X. laevis Dsp.L and Dsp.S homologs.  
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B.1. OVERALL SEQUENCE COMPARISON REVEALED CONSERVED GENE AND 
PROTEIN SEQUENCE BETWEEN X. LAEVIS AND MAMMALIAN SPECIES 
The first step was to determine the homology of X. laevis Dsp to homologs in mammalian 
species, H. sapiens and M. musculus. Bioinformatic analysis revealed that the H. sapiens coding 
region shared 65.7% identity with the X. laevis dsp.L homolog. M. musculus coding region shared 
64.4% identity with X. laevis dsp.L. The H. sapiens and M. musculus desmoplakin proteins each 
shared 66% identity with X. laevis Dsp.L (Table 1.6). Together, these results indicate that the X. 
laevis Dsp.L shares a high degree of similarity with mammalian homologs, suggesting conserved 
function. 
 
B.2. COMPARISON OF DESMOPLAKIN FUNCTIONAL DOMAINS REVEALED 
CONSERVATION BETWEEN X. LAEVIS AND MAMMALIAN SPECIES 
A multiple sequence alignment of all three homologs revealed stretches of conserved 
amino acid sequences (Appendix A.1). The next step was to determine the similarities of 
individual domains in the X. laevis desmoplakin protein with those in mammalian Dsp homologs. 
First, a comparative analysis of the plakin domain was performed. Comparative analysis revealed 
that the plakin domains of both Homo sapiens and Mus musculus homologs shared 64% identity 
and 80% similarity respectively with the same domain of X. laevis Dsp.L. (Fig. 1.3, Part I). A 
bioinformatics analysis of the plakin subdomains also revealed similarity in sequences between X. 
laevis and mammalian desmoplakin homologs (Appendix A.3). Next, the rod domain was 
compared across species. Comparative analysis revealed that the rod domain of H. sapiens and M. 
musculus homologs shared 61% identity and 82% similarity with the corresponding domain in X. 
laevis Dsp.L. (Fig. 1.3, Part I). Finally, the similarities of the A, B, and C subdomains in the C-
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terminal domain were analyzed. The A, B, and C subdomains in both H. sapiens and M. musculus 
shared 87%, 91%, and 93% similarity, respectively, with the corresponding regions in X. laevis 
Dsp.L. (Table 1.7; Fig. 1.3, Part I). Together, these results indicate that the functional domains 
of X. laevis Dsp.L share a high degree of similarity with those in the mammalian homologs, 
suggesting that its overall function could also be shared. 
 
B.3. COMPARING X. LAEVIS L AND S SUBGENOME HOMOLOGS REVEALED SIZE 
DIFFERENCES 
The desmoplakin allele is present in both the L (Long) and S (Short) subgenomes in X. 
laevis. The S subgenome has experienced more deletions, thus it might be predicted that L and S 
homologs differ in coding sequence length. Therefore, to determine whether there were 
differences, pairwise alignments were performed between the gene coding DNA sequence and 
protein sequences of these homologs. Results revealed that the X. laevis dsp.S gene coding DNA 
sequence shared 91% identity with dsp.L (Table 1.6). At the protein level, Dsp.S had a length of 
2767 a.a., which was 96.5% of the length of Dsp.L, and shared 93% similarity.  
Next, the similarity of the functional domains between the homologs was analyzed. The 
plakin domain of the Dsp.S homolog shared 86% similarity with the same domain in Dsp.L. 
Analysis of the coding DNA sequence alignment revealed a gap in the S homolog which 
corresponded to exons 11 and 12 in the L homolog (Appendix A.2). This encodes part of the SR56 
plakin subdomain which only shared 60% similarity between the homologs (Table 1.7). The rod 
domain of the Dsp.S homolog shared a 96% similarity with the corresponding domain in Dsp.L. 
The C-terminal domain in the Dsp.S homolog was predicted to contain A, B, and C subdomains 
and shared 98%, 97% and 99% similarity, respectively, with the same subdomains in Dsp.L (Fig. 
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1.3, Part II). Together, these results suggest that Dsp.S shares a high degree of similarity with 
Dsp.L but has deletions within the plakin domain, which might result in functional differences.  
 
C. IMMUNOFLUORESCENCE REVEALED DIFFERENCE IN PATTERNS 
BETWEEN EARLY AND LATE STAGES 
 
C.1. IMMUNOFLUORESCENCE REVEALED VARIABLE LEVELS OF 
DESMOPLAKIN WITHIN EPIDERMAL TISSUES AT EARLY STAGES 
As mentioned above, the ubiquitous presence of desmoplakin in all desmosomes makes it 
suitable to study the role of desmosomes during development. While the results above revealed 
that desmosomes are detected in the X. laevis embryonic epidermis, it is unknown if desmoplakin 
localizes to the membrane during this period. Therefore, the pattern of desmoplakin localiza t ion 
when the epidermis undergoes morphogenesis was determined using Immunofluorescence (IF) at 
st. 21-23 (23-25 hpf). Desmoplakin appeared to be adjacent to the membrane (marked by β-
catenin) throughout the epidermis (n=15, 3 experiments, Fig. 1.4A-A’’). However, the levels of 
both β-catenin and desmoplakin were not the same in all cells. At the vertex of 4 to 5 surrounding 
cells, consistent with where cells are fated to intercalate, there appeared to be lower levels of both 
β-catenin and desmoplakin (white arrow, Fig. 1.4A). Other cells with small apical surfaces, 
consistent with newly intercalating cells, had enriched levels of desmoplakin but not β-catenin 
(white arrowhead, Fig. 1.4A). In summary, the variable levels of desmoplakin within the epidermis 
suggest that desmosome assembly might be dynamic during epidermal development. 
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C.2. IMMUNOFLUORESCENCE REVEALED PRESENCE OF DESMOPLAKIN IN 
EPIDERMALLY-DERIVED TISSUES AT LATE STAGES 
As the Xenopus embryo approaches pre-metamorphic stages, many structures are derived 
from the developing epidermis. These include the outer corneal layer of the eye, and the 
operculum, which have desmosomes (Hu et al., 2013; Nieuwkoop and Faber, 1967). Therefore, 
desmoplakin was imaged by IF in these epidermally-derived structures at st. 42-43 (80-92 hpf). 
Results revealed ubiquitous levels of desmoplakin in the outer corneal layer (Fig. 1.4B-B’’). 
Desmoplakin was also present throughout the epidermis including the tail fin (Fig. 1.4C-C’) and 
was detected in the operculum and the external gills, which are derived from the visceral arches 
(Fig. 1.4D-D’’). These results indicate that desmoplakin presence in many epidermally-der ived 
tissues might suggest a requirement for proper development or functioning of these structures. 
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Figure 1.2: Transmission Electron Microscopy (TEM) analysis of the X. laevis embryonic 
desmosome during early development. 
 (A-B) TEM imaging revealing desmosomal ultrastructure in the Xenopus laevis embryo without 
(A) and with (B) midline (white arrow) (Scale bar=100 nm). (C-J) Electron micrographs depicting 
desmosomes in the X. laevis embryo at various developmental stages (electron-dense plaques, 
yellow arrows) (Scale bar = 250 nm). Green bracket (C) indicates Tight junction and Adherens 
junction. (K) Graph depicting the percentage of junctions with desmosomes at various stages. (L) 
Electron micrograph of st. 31 epidermis revealing desmosomes in the inner epidermal layer (red 
arrow) (Scale bar=0.5µm). Yellow arrows denote desmosomes in the outer epidermal layer. (M) 
Electron micrograph of st. 44 epidermis revealing desmosomes in the inner epidermal layer (red 
arrow) (Scale bar=1µm). Yellow arrows denote desmosomes in the outer epidermal layer and 
green arrow denote desmosomes between outer and inner epidermal layer. EC=Extracellular 
space; PM=Plasma membrane; ODP=Outer dense plaque; IDP=Inner dense plaque; DM=Dense 
midline; OL=Outer Layer; IL=Inner Layer. 
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Figure 1.3: Comparative bioinformatics analysis of the desmoplakin protein. 
Part I. Comparative analysis of functional domains in desmoplakin protein between vertebrate 
species and the X. laevis Dsp.L homolog. Part II. Comparative analysis of functional domains in 
desmoplakin protein between the X. laevis Dsp.L and Dsp.S subgenome homologs. Percent 
Similarity with X. laevis Dsp.L is denoted for each domain within boxes. Numbers below boxes 
depict amino acid coordinates for each domain. A,B,C=C-terminal homologous plakin repeat 
domains. 
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Figure 1.4: Desmoplakin expression in the developing embryo. 
(A-A’’) Immunofluorescence of desmoplakin (green) and β-catenin (red) at st. 22. Some cells have 
relatively high desmoplakin intensity (white arrowheads) and other cells have lower levels (white 
arrow) (Scale bar=25µm). (C-E’’) Immunofluorescence of desmoplakin (green) and nuclei 
(purple) in Eye (B-B’’), Fin (C-C’’) and Gill (D-D’’) epidermis at st. 43 (Scale bar=50µm). 
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Table 1.5: Percentage of junctions with desmosomes in various developmental stages in the 
X. laevis embryo. 
Stage Embryo No. of 
junctions 
analyzed 
Percentage of junctions 
0 
desmosomes/ 
junction 
1 
desmosome/ 
junction 
2 
desmosomes/ 
junction 
N≥3 
desmosomes/ 
junction 
st. 10 1 12 66.67 
(n=8) 
33.33 
(n=4) 
0 
(n=0) 
0 
(n=0) 
2 27 74.07 
(n=20) 
25.93 
(n=7) 
0 
(n=0) 
0 
(n=0) 
st. 14 1 12 41.67 
(n=5) 
58.33 
(n=7) 
0 
(n=0) 
0 
(n=0) 
2 39 51.28 
(n=20) 
46.15 
(n=18) 
2.56 
(n=1) 
0 
(n=0) 
st. 19 1 16 25 
(n=4) 
62.5 
(n=10) 
12.5 
(n=2) 
0 
(n=0) 
2 44 22.73 
(n=10) 
70.45 
(n=31) 
6.82 
(n=3) 
0 
(n=0) 
st. 22 1 17 0 
(n=0) 
41.18 
(n=7) 
52.94 
(n=9) 
5.88 
(n=1) 
2 51 9.8 
(n=5) 
35.29 
(n=18) 
45.1 
(n=23) 
9.8 
(n=5) 
 
 
 
 
 
 
 
 
51 
 
Table 1.6: Desmoplakin gene and protein comparative analysis against X. laevis Dsp.L. 
Organism Accession 
number or 
Database 
Whole Protein 
(%Identity/ 
Similarity) 
Length (amino 
acid) 
Coding DNA 
sequence 
(%Identity) 
X. laevis 
(Dsp.L) 
Xenbase 
Genome build 
9.1 
100 2866 100 
H. sapiens NP_004406 
 
66.0/ 82.2 2871 65.7 
M. musculus NP_076331 
 
65.6/ 82.1 2883 64.4 
X. laevis (Dsp.S) Xenbase 
Genome build 
9.1 
90.1/ 93.4 2767 90.7 
 
Table 1.7: Desmoplakin protein domains comparative analysis against X. laevis Dsp.L. 
Organism PLAKIN 
(%Identity/ 
Similarity) 
ROD 
(%Identity/ 
Similarity) 
A  
(%Identity/ 
Similarity) 
B  
(%Identity/ 
Similarity) 
C  
(%Identity/ 
Similarity) 
X. laevis 
(Dsp.L) 100 100 100 100 100 
H. sapiens 
64.6/ 80.5 61.1/ 81.8 72.6/ 86.9 84.6/ 93.0 76.0/ 91.4 
M. musculus 
64.3/ 80.0 60.8/ 81.9 71.4/ 87.4 84.6/ 93.4 75.4/ 91.4 
X. laevis 
(Dsp.S) 82.7/ 85.9 92.7/ 95.7 93.7/ 98.3 96.0/ 97.4 94.3/ 98.9 
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SECTION 2: EMBRYOS WITH REDUCED OR IMPAIRED DESMOPLAKIN 
FUNCTION HAVE EPIDERMAL DEFECTS, REDUCED MECHANICAL 
RESISTANCE, AND IMPAIRED RADIAL INTERCALATION 
 
Although the role and regulation of desmoplakin has been studied extensively in cell 
culture, there are only a handful of studies examining its role in the developing embryo (Gallicano 
et al., 2001; Gallicano et al., 1998). Therefore, the goal of this section is to determine the function 
of desmoplakin in the early embryo by performing loss-of-function experiments using various 
molecular techniques. 
  
PART I 
A. KNOCKDOWN WITH MORPHOLINOS RESULTS IN REDUCED 
DESMOPLAKIN 
To understand the role of a protein during development it is necessary to decrease or 
deplete that protein and assess the effects on the embryo. To do this, first, antisense morpholinos 
were used to knock down desmoplakin in embryos. Morpholino concentrations can be optimized 
to examine the effects of decreasing the dosage of Dsp in the embryo.  This is especially useful 
when a complete knockout might be lethal (Gallicano et al., 1998). While morpholinos are an 
effective method to test the role of gene function in Xenopus, effects due to toxicity, nonspecific 
effects, or the creation of neomorphs can lead to misleading results (Blum et al., 2015; Eisen and 
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Smith, 2008; Heasman, 2002). Thus, two splice-blocking morpholinos targeting different regions 
of the dsp.L homolog were used in this study.  
Two splice-blocking morpholinos against desmoplakin were designed to target either the 
exon 4-intron 4 splice junction (DspMO1) (Fig. 1.5A) or the exon 14-intron 14 splice junction, 
(DspMO2) (Fig. 1.5B) of Dsp.L mRNA. Additionally, DspMO2, but not DspMO1 is predicted to 
bind efficiently to Dsp.S mRNA (Table 1.1). To assess their efficacy, fertilized eggs were injected 
with DspMO1, DspMO2, control (CMO) or no morpholino (pools of n=10, 2 experiments each). 
First, the efficacy of DspMO1 was assessed against RNA from tailbud stages (st. 30-31). RT-PCR 
of the DspMO1 target region revealed a single 422 bp band in DspMO2-, CMO-injected and wild-
type embryos (Fig. 1.5C). However, in DspMO1-injected embryos, an extra 253 bp band, 
consistent with exon 4 splicing, was observed (Fig. 1.5C). These results indicate that the DspMO1 
morpholino produced splicing defects within the target region and a reduction in normal Dsp 
mRNA. The next step was to determine the efficacy of the DspMO2 morpholino. RT-PCR of the 
DspMO2 target region revealed a single 388 bp band in CMO-injected and wild-type embryos 
(Fig. 1.5D). However, an extra ~500 bp band, consistent with intron retention, was observed (Fig. 
1.5D). These results indicate that the DspMO2 morpholino produced splicing defects within the 
target region and a reduction in normal Dsp mRNA. 
To determine whether the splicing defects resulting from the DspMO1 were effective in 
reducing protein levels, embryos were imaged using immunofluorescence to detect desmoplakin 
levels. Results revealed that CMO-injected embryos had a normal intensity and pattern of Dsp as 
described above (Section 1C) (Fig. 1.5E). However, in both DspMO1- and DspMO2-injected 
embryos, there was a reduction in desmoplakin (Fig. 1.5F,G). These results indicate that the 
morpholinos effectively lead to reduction in desmoplakin in the epidermis.  
 
 
54 
 
 
B. CRISPR/ CAS9-MEDIATED MUTAGENESIS OF DESMOPLAKIN HOMOLOGS 
IN F0 MUTANTS RESULTS IN REDUCTION OF DESMOPLAKIN 
While the results above confirm that morpholinos effectively target Dsp, using different 
approaches to study gene and protein function ensures the validity of phenotypes (Blum et al., 
2015; Kok et al., 2015). Additionally, morpholino efficacy starts to decrease after a few days 
(Eisen and Smith, 2008). Therefore, the CRISPR/Cas9 (clustered regularly interspaced short 
palindromic repeats/CRISPR-associated) system was utilized for targeted mutagenesis of the dsp 
gene (Bhattacharya et al., 2015; Nakayama et al., 2013; Wang et al., 2015). This method creates 
double stranded breaks in the genome which frequently lead to indels due to the error-prone non-
homologous end joining repair mechanism. To generate F0 dsp CRISPR mutants, gRNAs were 
designed to target both the L and S homologs. To ensure that the technique was effective, a positive 
control was performed by targeting the tyrosinase (tyra + tyrb) genes as previously described 
(Chapter 2) (Wang et al., 2015). Two CRISPR gRNAs were designed to target sites in the eighth 
(DspCRISPR1) and nineteenth (DspCRISPR2) exons of the dsp.L homolog (corresponding to the 
eighth and seventeenth exons on the dsp.S homolog, respectively) (Fig. 1.6A). To determine 
whether the gRNAs were effective, injected embryos were analyzed for mutations using a T7 
endonuclease assay. If mutations are present, the target region is cleaved. First, the efficacy of 
DspCRISPR1 was determined using DNA from tailbud stages (st. 30-31). Results revealed a 237 
bp (dsp.L) and 380 bp (dsp.S) band in 100% of wild-type embryos (n=12, 3 experiments). 
However, in 80% of DspCRISPR1-injected embryos, multiple bands, including the 237 bp and 
380 bp bands, were detected in both dsp.L and dsp.S homologs (n=15, 3 experiments) (Fig. 1.6B). 
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The sizes of these extra bands are consistent with mutations in the gRNA target region (Table 1.4). 
This indicates that the gRNA was effective and that the embryos were mosaic. 
Next, the efficacy of DspCRISPR2 was assessed using DNA from tailbud stages (st. 30-
31). Results revealed a 382 bp (dsp.L) and 325 bp (dsp.S) band in 100% of wild-type embryos 
(n=12, 3 experiments). However, in 100% of DspCRISPR2-injected embryos, multiple bands, 
including the 382 bp and 325 bp bands, were detected in both dsp.L and dsp.S homologs (n=16, 3 
experiments) (Fig. 1.6B). The sizes of these extra bands are consistent with mutations in the gRNA 
target region (Table 1.4). This indicates that the gRNA was effective and that DspCRISPR2-
injected embryos were also mosaic, similar to DspCRISPR1-injected embryos. 
The next goal was to determine whether the mutations in the target region led to a reduction 
in desmoplakin protein. To do this, embryos were imaged by immunofluorescence to detect 
desmoplakin presence in F0 mutants. Results revealed that control embryos had a normal pattern 
of Dsp labeling as described above (Section 1C) (Fig. 1.6C). However, in both DspCRISPR1 and 
DspCRISPR2 F0 mutants, there was a reduction in desmoplakin. There was some variability in 
the amount of desmoplakin loss between individual CRISPR-injected embryos. For example, in a 
subset of embryos there were low levels of desmoplakin across a wide region of epidermis (Fig. 
1.6D,F). On the other hand, other embryos displayed a reduction in desmoplakin in smaller patches 
of epidermis (Fig. 1.6E,G). This suggests that the degree of mosaicism is different between 
injected embryos (Wang et al., 2015). These results indicate that CRISPR-mediated mutagenes is 
of desmoplakin L and S homologs is effective at reducing desmoplakin protein. 
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PART II 
A. DSP MORPHANTS AND F0 MUTANTS HAVE REDUCED SIZE 
 
Morpholinos successfully resulted in reduction of desmoplakin protein in embryos. The 
next step was to observe the effects on the morphology of embryos injected with morpholino and 
CRISPR gRNA. First, DspMO1 morphants were assessed for defects. Embryos appeared normal 
at cleavage, blastula, and gastrula stages (until 13 hpf). However, at stage 25-30, a large percentage 
of DspMO1 morphants were shorter. DspMO1 morphants (n=98, 4 experiments) were, on average, 
1.45-fold shorter than control morphants (n=77, 4 experiments) (t-test, p<0.0001) (Fig. 1.7A). 
Next, DspMO2 morphants were observed to determine if the phenotypes mimicked those of the 
DspMO1 morphants. Embryos were able to progress through cleavage, blastula, and gastrula 
stages (until 13 hpf) normally. However, like DspMO1 morphants at stage 25-30, a large 
percentage of DspMO2 morphants were also shorter. DspMO2 morphants (n=67, 3 experiments) 
were, on average, 1.35-fold shorter than control morphants (n=76, 3 experiments) (t-test, 
p<0.0001) (Fig. 1.7B). 
To ensure the specificity of morphant phenotypes, CRISPR/ Cas9 mutants were examined 
to determine whether they mimicked morphants. Embryos were able to progress through cleavage, 
blastula, and gastrula stages (until 13 hpf) normally. F0 mutant embryos that were sequenced and 
found to have mutations in both dsp homologs were imaged prior to genotyping. Like the Dsp 
morphants at stage 25-30, these mutants were also shorter. D'Agostino & Pearson omnibus 
normality testing revealed that the distribution of length measurements was not normal 
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(DspCRISPR1=p<0.0001; DspCRISPR2= p<0.001). Non-parametric statistical analysis revealed 
that DspCRISPR1 (n=109, 2 experiments) and DspCRISPR2 (n=90, 2 experiments) F0 mutants 
had statistically significant reductions in length (Mann-Whitney test, p<0.0001) relative to wild-
type embryos (Fig. 1.7C,D). 
 
B. DSPMO1 AND DSPMO2 MORPHANTS EXHIBIT DEFECTS IN 
EPIDERMALLY-DERIVED STRUCTURES AND THE HEART 
 
B.1. DSPMO1 AND DSPMO2 MORPHANTS HAVE EPIDERMAL DEFECTS AT 
EARLY STAGES 
 
At early stages (st. 25-30), embryos also displayed epidermal tears, hyperpigmentat ion, 
ventral abdominal blistering and neural tube defects in DspMO1 and DspMO2 morphants. 
Analysis of DspMO1 and DspMO2 morphants were performed separately. While 39.8% of 
DspMO1 morphants had skin defects (n=296, 6 experiments), this was present in only 3.62% of 
controls (n=276, 6 experiments) (χ2-test, p= 3.34E-25) (Fig. 1.8B). Skin defects occurred in 
27.47% of DspMO2 morphants (n=233, 4 experiments) compared to only 3.41% of control 
morphants (n=205, 4 experiments) (χ2-test, p= 9.39E-12) (Fig. 1.8C). Ventral blisters were present 
in 29.25% of DspMO1 morphants (n=294, 6 experiments) compared to only 6.16% of controls 
(n=276, 6 experiments) (χ2-test, p= 8.03E-13) (Fig. 1.8D). Ventral blisters were present in 17.17% 
of DspMO2 morphants (n=233, 4 experiments) compared to only 2.93% of control morphants 
(n=205, 4 experiments) (χ2-test, p= 0.00039) (Fig. 1.8E). While 16.33% of DspMO1 morphants 
had neural tube closure defects (n=294, 6 experiments), none of the control morphants presented 
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with these defects (n=276, 6 experiments) (χ2-test, p= 2.31E-12) (Fig. 1.8F). Finally, while 15.02% 
of DspMO2 morphants had neural tube closure defects (n=233, 4 experiments), only 1.46% of the 
controls presented with these defects (n=205, 4 experiments) (χ2-test, p= 4.91E-07) (Fig. 1.8G). 
These results suggest that DspMO1 and DspMO2 morpholinos are associated with defects in size, 
epidermal development, and neural tube closure of embryos (Fig. 1.8O). These results also reveal 
that defects in both morphants mimic each other, suggesting that these phenotypes are specific to 
desmoplakin loss at early stages. 
 
B.2. DSPMO1 AND DSPMO2 MORPHANTS HAVE EYE, FIN, AND HEART DEFECTS 
AT LATE STAGES 
Results revealed that desmoplakin is present in epidermally-derived structures such as the 
lens, fin, and external gill buds in late tailbud stage embryos (>50 hpf). Desmoplakin is also known 
to be expressed in the mammalian heart, which becomes functional during Xenopus late tailbud 
stages (Lohr and Yost, 2000; Warkman and Krieg, 2007). Therefore, the next step was to determine 
whether Dsp loss disrupted the development of these structures. Analysis of DspMO1 and 
DspMO2 morphants were performed separately. Several defects were noticeable in DspMO1 and 
DspMO2 morphants at stage 41-43. The reduction in anterio-posterior axis length is still retained 
from mid-tailbud stages but this was not quantified. While control morphants appeared unaffected, 
many DspMO1 and DspMO2 morphants did not develop proper eye structures, and displayed 
ruffled fins and pericardial or cardiac edemas. Eye defects, including defects in RPE pigmenta t ion 
occurred in 44.77% of DspMO1 morphants (n=62, 2 experiments) compared to only 5.45% of 
control morphants (n=55, 2 experiments) (χ2-test, p= 5.61E-07) (Fig. 1.8I). Similar eye defects 
occurred in 63.16% of DspMO2 morphants (n=76, 2 experiments) compared to only 7.25% of 
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control morphants (χ2-test, p= 2.91E-12) (n=69, 2 experiments) (Fig. 1.8J). Fin defects were 
present in 53.23% of DspMO1 morphants (n=62, 2 experiments) compared to only 1.82% of 
control morphants (n=55, 2 experiments) (χ2-test, p= 6.79E-120) (Fig. 1.8K). While fin defects 
were present in 38.16% of DspMO2 morphants (n=76, 2 experiments), none of the controls 
displayed these defects (n=69, 2 experiments) (χ2-test, p= 9.65E-09) (Fig. 1.8L). Cardiac defects 
were present in 17.74% of DspMO1 morphants (n=62, 2 experiments), while only 1.82% of control 
morphants exhibited these defects (n=55, 2 experiments) (χ2-test, p= 8.51E-89) (Fig. 1.8M). While 
50% of DspMO2 morphants also exhibited cardiac defects (n=76, 2 experiments), only 2.9% of 
controls displayed these defects (n=69, 2 experiments) (χ2-test, p= 2.33E-10) (Fig. 1.8N). These 
results suggest that the DspMO1 and DspMO2 morpholinos perturb the development of many 
epidermally-derived structures as well as other desmosome-containing tissues such as the heart 
(Fig. 1.8O; Table 1.8). These results also indicate that both morpholinos mimic each other at late 
stages, suggesting that these defects are specific to Dsp knockdown. 
 
C. DSP CRISPR MUTANTS MIMIC MORPHANT PHENOTYPES AT EARLY AND 
LATE STAGES 
 
C.1. DSP MUTANTS HAVE REDUCED SIZE AND EPIDERMAL DEFECTS AT 
EARLY STAGES 
 
At these early stages, defects appeared similar to morphants, including epidermal tears, 
hyperpigmentation, ventral abdominal blistering and neural tube defects. Skin defects occurred in 
7.3% of DspCRISPR1 (n=219, 4 experiments) and 8.18% of DspCRISPR2 F0 mutants (n=232, 4 
 
 
60 
 
experiments) compared to only 0.78% of wild-type embryos (n=256, 4 experiments) (χ2-test, 
DspCRISPR1, p=0.00021; DspCRISPR2, p=5.64E-05) (Fig. 1.9A-C). Ventral blisters were 
present in 10.95% of DspCRISPR1 (n=219, 4 experiments) and 12.06% of DspCRISPR2 F0 
mutants (n=232, 4 experiments) compared to only 1.56% of wild-type embryos (n=256, 4 
experiments) (χ2-test, DspCRISPR1, p=1.46E-05; DspCRISPR2, p=2.83E-06) (Fig. 1.9D,E). 
Finally, while 5.48% of DspCRISPR1 (n=219, 4 experiments) and 5.17% of DspCRISPR2 F0 
mutants (n=232, 4 experiments) had neural tube defects, no wild-type embryos presented with 
these defects (n=256, 4 experiments) (χ2-test, DspCRISPR1, p=0.00015; DspCRISPR2, 
p=0.00023) (Fig. 1.9F,G). 
These results indicate that phenotypes of CRISPR-injected embryos mimic those observed 
in morphants at early stages, suggesting that these phenotypes are specific to desmoplakin loss. 
However, the lower prevalence relative to morphants, compounded with variability observed with 
desmoplakin labeling suggest that these mutants are mosaic. 
 
C.2. DSP MUTANTS HAVE EYE, FIN, AND HEART DEFECTS AT LATE STAGES 
Next, CRISPR/ Cas9 F0 mutants were examined to determine whether they mimicked 
morphants at late stages. The reduction in anterio-posterior axis length is still retained from mid-
tailbud stages but this was not quantified. While wild-type controls appeared unaffected, many 
DspCRISPR1 and DspCRISPR2 F0 mutants did not develop proper eye structures including RPE 
and displayed ruffled fins and cardiac edemas. Eye defects, including defects in RPE pigmenta t ion 
and colobomas occurred in 13.33% of DspCRISPR1 (n=165, 3 experiments) and 8.05% of 
DspCRISPR2 F0 mutants (n=174, 3 experiments) compared to only 1.41% of wild-type embryos 
(n=213, 3 experiments) (χ2-test, DspCRISPR1, p=1.62E-08; DspCRISPR2, p=0.0015) (Fig. 1.9H-
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J). Fin defects were present in 9.09% of DspCRISPR1 (n=165, 3 experiments) and 8.05% of 
DspCRISPR2 F0 mutants (n=174, 3 experiments) while only 0.47% of wild-type embryos 
displayed fin defects (n=213, 3 experiments) (χ2-test, DspCRISPR1, p=7.61E-09; DspCRISPR2, 
p=0.00012) (Fig. 1.9K,L). Finally, cardiac defects, including cardiac edemas were quantified in 
morphants were present in 10.91% of DspCRISPR1 (n=165, 3 experiments) and 8.05% of 
DspCRISPR2 F0 mutants (n=174, 3 experiments) while only 0.47% of wild-type embryos 
displayed cardiac defects (n=213, 3 experiments) (χ2-test, DspCRISPR1, p=4.08E-06; 
DspCRISPR2, p=0.00012) (Fig. 1.9M,N). These results indicate that phenotypes of CRISPR-
injected embryos mimic those observed in morphants at late stages also, suggesting that these 
phenotypes are specific to Dsp loss. However, the lower prevalence relative to morphants, 
compounded with variability observed in Dsp labeling, suggest that these mutants are mosaic (Fig. 
1.9O; Table 1.9). 
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PART III 
A. THE EPIDERMIS OF DSP MORPHANTS IS SUSCEPTIBLE TO DAMAGE BY 
MECHANICAL STRESS 
Epidermal tearing was observed in Dsp morphants and CRISPR F0 mutants. Patients with 
mutations in desmoplakin and plakophilin 1 also have skin that is prone to tearing when exposed 
to mechanical agitation (McGrath et al., 1997; Whittock et al., 2002). Therefore, the next step was 
to determine whether a reduction of desmoplakin in Xenopus embryos also results in a reduced 
resistance to mechanical stresses. 
 
A.1. THE EPIDERMIS OF DSP MORPHANTS IS SUSCEPTIBLE TO DAMAGE BY 
SHEAR AND IMPACT FORCES 
First, an “Impact Assay” was used where in st. 26 embryos were picked up using a pipette 
and released from a height of 15 cm into a dish lined with 2% agarose (Fig. 1.10A).  This assay 
was predicted to cause shear and impact stresses. Results revealed that more DspMO1 morphants 
(85%) exhibited damage to the epidermis compared to controls (15%) (n=20, 2 experiments) (χ2-
test, p=9.54E-06) (Fig. 1.10B-D’). These results indicate that the epidermis of DspMO1 morphants 
exhibits quantitatively decreased resistance to shear and impact forces. 
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A.2. THE EPIDERMIS OF DSP MORPHANTS IS SUSCEPTIBLE TO DAMAGE BY 
ROTATIONAL FORCES 
Next, a “Rotation Assay” was used where in st. 26 embryos were placed in a buffer-
containing 50 ml conical tube that underwent rotations at 55rpm (t=30s) in a vertical rotating mixer 
(Fig. 1.10E). The embryos were subject to various mechanical stresses as they contacted the 
surface tension of the media as well as the side of the tube. Results revealed that significantly more 
DspMO1 morphants (80%) exhibited damage to the epidermis compared to controls (25%) (n=20, 
2 experiments) (χ2-test, p=0.00048) (Fig. 1.10F-H’). These results indicate that the epidermis of 
DspMO1 morphants exhibit reduced resistance to tension and shear forces. 
Together, these mechanical assays demonstrate that the epidermis of DspMO1 morphants 
have quantitatively decreased resistance to mechanical stress such as impact, shear and tensional 
forces. This suggests that reduction in desmoplakin may contribute to decreased mechanica l 
resistance of the epidermis. 
 
B. DSP MORPHANTS EXHIBIT A LOSS OF JUNCTIONAL DESMOSOMES AND 
WIDENED INTERCELLULAR GAP 
Next, the desmosome structure was examined in Dsp morphants to determine whether Dsp 
is required for desmosome formation or maintenance. Desmosomes were imaged by TEM to 
observe and quantify the desmosomal junctions in the  embryonic epidermis at st. 30-31 (72-76 
hpf). There was an increase in the intercellular gap in DspMO1 morphants relative to controls. 
This intercellular gap was  increased basal to tight and adherens junctions (not quantified, arrows, 
Fig. 1.11A-D). Results also revealed that 57% of junctions in DspMO1 morphants had 
desmosomes compared to 97% of junctions in controls (n=44 (CMO) and n=56 (DspMO1) in 2 
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embryos, 2 experiments) (Fig. 1.11E). Additionally, while only 2% of junctions in DspMO1 
morphants had three or more desmosomes, 27% of junctions in controls had three or more 
desmosomes (Table 1.10). These results suggest that desmoplakin may be required for proper 
formation or maintenance of the desmosome and maintaining intercellular adhesion. 
 
C. DSP MORPHANTS HAVE DEFECTS IN THE FORMATION OF SPECIALIZED 
EPIDERMAL CELL TYPES 
The Xenopus embryonic epidermis has multiple specialized cell types. Since the epidermis 
of Dsp morphants appeared abnormal, the development of these cells might also be affected in 
Dsp morphants. Therefore, the α-tubulin of multiciliated cells (MCCs) was imaged by 
immunofluorescence (Fig. 1.12A). At st. 31, cilia appeared shorter and fewer in number per cell 
in DspMO1 morphants compared to controls (Fig. 1.12B). The number of cilia-positive cells 
relative to the total number of cells was 2.77-fold less in the DspMO1 morphants (0.064; n=9) 
relative to controls (0.178; n=9, 2 experiments) (t-test, p<0.00001) (Fig. 1.12B-D).  
To determine whether the reduction in multiciliated cells in DspMO1 morphants was due 
to desmoplakin loss, MCCs were also counted in DspMO2 morphants injected at the 1-cell stage. 
At st. 31, cilia appeared shorter and fewer in number per cell in DspMO2 morphants compared to 
controls, similar to DspMO1 morphants (Fig. 1.12E). The number of cilia-positive cells relative 
to the total number of cells was 2.09-fold less in the DspMO2 morphants (0.087; n=8) relative to 
controls (0.181; n=9, 2 experiments) (t-test, p<0.00001) (Fig. 1.12E-G). Together, these results 
indicate that Dsp morphants display impaired development of multiciliated cells.  
Next, the Lectin Peanut Agglutinin (Lectin PNA) was labeled to determine whether the 
development of small secretory cells (SSCs) was affected in Dsp morphants (Fig. 1.13A). At st. 
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34, the number of PNA-positive cells relative to the total number of cells was 5.79-fold less in the 
DspMO1 morphants (0.023; n=11) relative to controls (0.139; n=10, 2 experiments) (t-test, 
p<0.00001) (Fig. 1.13B-D).  
To determine whether the reduction in small secretory cells in DspMO1 morphants was 
due to desmoplakin loss, SSCs were also counted in DspMO2 morphants injected at the 1-cell 
stage. At st. 34, the number of PNA-positive cells relative to the total number of cells was 3.74-
fold less in the DspMO2 morphants (0.031; n=10) relative to controls (0.115; n=10, 2 experiments) 
(t-test, p<0.00001) (Fig. 1.13E-G). Together, these results indicate that Dsp morphants have 
impaired development of small secretory cells.  
In summary, these results suggest that a reduction in Dsp may reduce the prevalence and 
perturb the development of specialized cell types that radially intercalate into the outer epidermis.  
 
D. DSP MORPHANTS HAVE DEFECTS IN RADIAL INTERCALATION 
Dsp morphants were demonstrated to have fewer and defective specialized cell types that 
radially intercalate into the outer epidermal layer. More precisely, there is a reduction in cilia-
positive multiciliated cells and Lectin PNA-positive small secretory cells in Dsp morphants. 
Therefore, the next step was to determine whether the reduction in the number of these cell types 
was a result of reduced radial intercalation. To track radial intercalation, the epidermis of control 
and DspMO1 morphants were pulse labeled with biotin from st.19 (46 hpf) until st. 20 (47 hpf) 
(Fig. 1.14A). Embryos fixed and labeled immediately after this treatment demonstrated complete 
and relatively uniform labeling of the epidermis (not shown). Biotin incubation was followed by a 
4-hour washout to allow unlabeled cells to emerge into the outer layer (Fig. 1.14A). 
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Controls fixed after this washout had many biotin-negative regions that were consistent ly 
interspersed among biotin positive cells (Fig. 1.14B-B’’). These unlabeled regions represented the 
cells that radially intercalated during the washout period.  Results revealed a significant, albeit 
slight reduction in the average number of unlabeled cells in DspMO1 morphants (t-test, p=0.0475) 
(n= 11, 3 experiments) (Fig. 1.14C-C’’). There was a large amount of variability, where a subset 
of DspMO1 morphant embryos had the same or even more unlabeled cells than a subset of the 
controls (Fig. 1.14D,D’’,E). There were also significantly fewer multiciliated cells in the same 
images of DspMO1 morphants (t-test, p<0.0000001, n= 11, 3 experiments; Fig. 1.14F). In some 
DspMO1 morphants, the size of the apical surfaces of many unlabeled cells appeared smaller 
(arrows, Fig. 1.14D). Therefore, the relative surface area of the biotin-negative cells was quantified 
in the same images. Results revealed that there was indeed a statistically significant reduction in 
the average surface area of biotin-negative cells in the DspMO1 morphants (n=822 cells, 11 
embryos) relative to controls (n=806 cells, 11 embryos) (Mann-Whitney test, p<0.0001, 3 
experiments) (Fig. 1.14G, H). A histogram analysis revealed that these apically emerging cells 
had surface areas that followed a binomial distribution with a substantial proportion of cells in 
CMO morphants greater than 100µm2. Together, these results indicate that radial intercalation and 
formation of the multiciliated cells in the embryonic epidermis may require Dsp. 
 
E. DSP MORPHANTS AND F0 MUTANTS HAVE ABNORMAL ORGANIZATION 
OF KERATIN INTERMEDIATE FILAMENTS 
Radial intercalation is partly orchestrated by the cytoskeleton through actin-generated 
forces and is also regulated by the rigidity of neighboring cells (Sedzinski et al., 2016). Therefore, 
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keratin intermediate filaments were imaged to determine whether Dsp morphants have 
perturbations in intermediate filament organization. 
To assess this, control and Dsp morphants at st. 30-31 (72-76 hpf) were fixed and labeled 
for keratin. Results revealed that keratin filaments appear as a contiguous network in controls 
(n=21, 4 experiments) (Fig. 1.15A-B). In DspMO1 morphants, however, keratin appeared to be 
retracted from the membrane and appeared to have gaps between networks in neighboring cells 
(n=12/16, 3 experiments) (Fig. 1.15C-D). The same results were observed in DspMO2 morphants 
(n=8/12, 2 experiments) (Fig.15E-F). CRISPR F0 mutants also displayed keratin retraction in a 
subset of embryos (Fig. 1.15, Part II). These results indicate that a reduction in Dsp disrupts the 
organization of keratin intermediate filaments, which may contribute to defects in morphogenes is.  
 
F. DISRUPTION OF DESMOPLAKIN-KERATIN LINK REPRODUCES SOME 
MORPHANT AND MUTANT PHENOTYPES 
Dsp morphants and CRISPR F0 mutants displayed retraction of keratin filaments. 
Therefore, the next step was to determine whether disrupting the link between desmoplakin and 
keratin while maintaining desmosome adhesion produced similar phenotypes. To test this, the 
established dominant-negative DP-NTP (Desmoplakin – N-terminal peptide) construct was 
injected into embryos (Huen et al., 2002) (Fig. 1.16A). This construct has a truncated human 
desmoplakin which is demonstrated to uncouple intermediate filaments from the desmosome. 
Membrane-GFP and wild-type embryos were used as controls. 
First, endogenous desmoplakin and keratin were imaged by immunofluorescence to 
determine the effect of DP-NTP on protein localization. Results revealed low endogenous 
desmoplakin in cells expressing DP-NTP and keratin retraction while appearing normal in controls 
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(Fig. 1.16B-E). These results indicate that DP-NTP replaces endogenous desmoplakin at the 
membrane and is associated with keratin reorganization. 
Next, DP-NTP-injected were examined to determine whether maintaining the desmosomal 
connection but abolishing the attachment to keratin mimicked the effects of desmoplakin 
reduction. Results revealed no defects during cleavage, blastula, or gastrula stages. When embryos 
developed into mid-tailbud stages (st. 30-31), hyperpigmentation was present in DP-NTP 
expressing regions (Fig. 1.16G, G’). The embryos also had a reduction in size, but no embryos 
displayed epidermal tearing. At late tailbud stages (st. 40-42), embryos displayed cardiac edemas 
and ruffled fins, although fin ruffling was less severe relative to morphants and mutants (Fig. 
1.16H,I). These results indicate that the effects of abolishing desmosome-keratin link partially 
overlap with those observed in Dsp knockdown or knockout techniques. This also suggests that 
loss of desmosomal adhesion may have relatively severe effects in embryonic development.  
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Figure 1.5: Desmoplakin depletion with antisense morpholinos. 
(A) Schematic of binding of DspMO1 to exons within dsp.L mRNA and resulting splice products.  
(B) RT-PCR of dsp.L reveals alternative splice products in DspMO1 morphants (black arrow) but 
not in control morphants (CMO) or wild-type (WT). (C) Schematic of binding of DspMO2 to 
exons within dsp.L mRNA and resulting splice products. (D) RT-PCR of dsp.L reveals alternative 
splice products in DspMO2 morphants (black arrow) but not in control morphants (CMO) or wild -
type (WT). (E-G) IF of desmoplakin (white) CMO (E), DspMO1 (F), and DspMO2 (G) morphants 
(Scale bar = 25 µm). 
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Figure 1.6: Desmoplakin depletion with CRISPR/ Cas9 mutagenesis. 
(A,B) Schematic of binding of DspCRISPR1 (A) and DspCRISPR2 (B) gRNA to exons within 
dsp.L and dsp.S. Black arrowheads represent primer locations. (C,D) T7 endonuclease I assay 
revealing mutations in DspCRISPR1 and DspCRISPR2 (Lanes 2,3 in C and D, respectively) F0 
mutants but not corresponding wild-type (Lanes 4,5 in C and D). Mutations are identified as 
presence of more than one band. HyperLadder 25 bp (Bioline) is in Lane 1. (E-I) IF of desmoplakin 
(white) in wild-type and DspCRISPR F0 mutants. Variability in desmoplakin reduction in 
DspCRISPR1 (F,G) and DspCRISPR2 (H,I) mutants (Scale bar = 50 µm). 
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Figure 1.7: Dsp morphants and mutants displayed reduction in size. 
(A) Box plot of size ranges between CMO and DspMO1 morphants. (B) Box plot of size ranges 
between CMO and DspMO2 morphants. (C) Box plot of size ranges between WT embryos and 
DspCRISPR1 mutants. (D) Box plot of size ranges between WT embryos and DspCRISPR2 
mutants. Boxes represent 25th (lower), 50th (median), and 75th (upper) percentiles. Whiskers 
represent 5th (lower) and 95th (upper) percentiles. Dots above and below whiskers are individua l 
embryos that have sizes outside the 5th and 95th percentile. 
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Figure 1.8: Desmoplakin knockdown with DspMO1 and DspMO2 results in size reduction, 
epidermal, and heart defects. 
(A-G) Phenotypes observed in CMO (A), DspMO1 (B,D,F), and DspMO2 (C,E,G) morphants at 
st. 31. (B,C) Epidermal tearing; (D,E) Blister; (F,G) Neural tube defects (yellow arrow). (H-N) 
Phenotypes observed in CMO (H), DspMO1 (I,K,M), and DspMO2 (J,L,N) morphants at st. 42. 
(I,J) Eye defects including coloboma; (K,L) Ruffled fin and reduced fin size; (M,N) Cardiac 
edema. (Scale bar; A-N = 1 mm). (O) Graph of relative prevalence of phenotypes in CMO, 
DspMO1, and DspMO2 morphants expressed as a percentage. 
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Figure 1.9: Desmoplakin knockdown with DspCRISPR1 and DspCRISPR2 results in size 
reduction, epidermal, and heart defects. 
(A-G) Phenotypes observed in WT (A), DspCRISPR1 (B,D,F), and DspCRISPR2 (C,E,G) 
morphants at st. 31. (B,C) Epidermal tearing; (D,E) Blister; (F,G) Neural tube defects (yellow 
arrow). (H-N) Phenotypes observed in WT (H), DspCRISPR1 (I,K,M), and DspCRISPR2 (J,L,N) 
morphants at st. 42. (I,J) Eye defects including coloboma; (K,L) Ruffled fin and reduced fin size; 
(M,N) Cardiac edema. (Scale bar; A-N = 1 mm). (O) Graph of relative prevalence of phenotypes 
in WT, DspCRISPR1, and DspCRISPR2 morphants expressed as a percentage. 
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Figure 1.10: Depleting desmoplakin reduces resistance of epidermis to impact and shear 
stresses. 
(A) Schematic of experimental design for the Impact Assay. (B) Bar graphs summarizing 
quantification of proportion of CMO and DspMO1 morphants with a ruptured epidermis after 
Impact Assay (mean±s.e.m.). (C-D’) Representative images of CMO (C.C’) and DspMO1 (D,D’) 
morphants after Impact Assay. (E) Schematic of experimental design for the Rotation Assay. (F) 
Bar graphs summarizing quantification of proportion of CMO and DspMO1 morphants with a 
ruptured epidermis after Rotation Assay (mean±s.e.m.). (G-H’) Representative images of CMO 
(G,G’) and DspMO1 (H,H’) morphants after Rotation Assay.  
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Figure 1.11: Depleting desmoplakin is associated with a loss of junctional desmosomes. 
(A-D) TEM micrograph of junctions in CMO (A,B) and DspMO1 (C,D) morphants (Scale bars = 
250 nm). Intercellular gap in DspMO1 morphants (black arrows in C,D). (E) Graph depicting the 
percentage of junctions with desmosomes in CMO and DspMO1 morphants. 
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Figure 1.12: Desmoplakin morphants have a reduction in multiciliated cells. 
(A) Schematic of morpholino injection and labeling for MCCs. (B-C’’) IF of α-tubulin (green) and 
E-cadherin (purple) in CMO (B-B’’) and DspMO1 (C-C’’) morphants (Scale bar  = 50μm). (D) 
Graph depicting ratio of cilia+ cells/ Total cells in CMO and DspMO1 morphants. (E-F’’) IF of α-
tubulin (green) and E-cadherin (purple) in CMO (E-E’’) and DspMO2 (F-F’’) morphants (Scale 
bar  = 25μm). (G) Graph depicting ratio of cilia+ cells/ Total cells in CMO and DspMO2 
morphants.  
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Figure 1.13: Desmoplakin morphants have a reduction in small secretory cells. 
(A) Schematic of morpholino injection and labeling for SSCs. (B-C’’) IF of Peanut Agglutinin or 
PNA (green) and E-cadherin (purple) in CMO (B-B’’) and DspMO1 (C-C’’) morphants (Scale 
bar  = 50μm). (D) Graph depicting ratio of PNA+ cells/ Total cells in CMO and DspMO1 
morphants. (E-F’’) IF of Peanut Agglutinin or PNA (green) and E-cadherin (purple) in CMO (E-
E’’) and DspMO2 (F-F’’) morphants (Scale bar  = 50μm). (G) Graph depicting ratio of PNA+ 
cells/ Total cells in CMO and DspMO2 morphants.  
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Figure 1.14: Desmoplakin morphants have a reduction in radial intercalation and surface 
area of intercalating cells. 
(A) Schematic of morpholino injection and biotin labeling to visualize apical emergence. (B-D’’) 
IF of Biotin label (red) and Multiciliated cells (purple) in CMO (B-B’’) and DspMO1 (C-D’’) 
morphants (Scale bar  = 50μm). Some intercalated cells in DspMO1 morphants have small apical 
surface (white arrows, D). (E) Box and whisker plot depicting ratio of Intercalated cells/ Total 
cells in CMO and DspMO1 morphants. (F) Box and whisker plot depicting ratio of Multiciliated 
cells/ Total cells in CMO and DspMO1 morphants. (G, H) Histograms depicting frequency and 
cumulative percentage of Surface Area of intercalated cells in a range of bin sizes in CMO (G) and 
DspMO1 (H) morphants. 
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Figure 1.15: Desmoplakin morphants (Part I) and F0 mutants (Part II) display abnormal 
organization of keratin intermediate filaments. 
(A-A’’) Immunofluorescence of keratin Type II (red) and membrane marked by β-catenin (green) 
in control embryos. (C-C’’) Immunofluorescence of keratin Type II with retraction from 
membrane in DspMO1 (Part I) and DspCRISPR1 (Part II) embryos. (E-E’’) Immunofluorescence 
of keratin Type II with retraction from membrane in DspMO2 (Part I) and DspCRISPR2 (Part II) 
embryos. Scale bar = 25µm. Inset: Magnified view of cell-cell junction. (B, D, F) Intensity profile 
for red and green channels along yellow arrow for control (B), DspMO1 and DspCRISPR1 (D), 
and DspMO2 and DspCRISPR2 (F) embryos. Arrow points to right side of the graph. Vertical 
blue line represents position of white marker on arrow. 
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Figure 1.16: Dominant-negative desmoplakin disrupts keratin linkage and is associated with 
hyperpigmentation, reduced size, and cardiac defects. 
(A) Schematic of wild-type Dsp (top) and a C-terminal deletion construct of Dsp, DP-NTP, tagged 
with EGFP (bottom). (B-B’’) IF of desmoplakin in mGFP-injected embryos. (C) IF of Keratin in 
mGFP-injected embryos. (D-D’’) IF of desmoplakin in DP-NTP-EGFP-injected embryos. (E) IF 
of Keratin in DP-NTP-EGFP-injected embryos. (Scale bar = 20 µm). (F-G’) mGFP-injected (F) 
and DP-NTP-injected (G) embryos at st. 30-31 with an enlarged view of the epidermis (F’, G’) 
(Scale bar = 1 mm). (H) mGFP-injected at st. 40-41. (I) DP-NTP-injected embryos at st. 40-41 
with cardiac defects and mild fin ruffling (white arrows) (Scale bar = 1 mm).  
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Table 1.8: Prevalence of phenotypes in Dsp morphants with p-values. 
Phenotype Control morphant (%) Dsp Morphant (%) p-value 
Skin defect 
3.62 39.8 (DspMO1) 3.34E-25 
3.41 27.47 (DspMO2) 9.39E-12 
Blister 
6.16 29.25 (DspMO1) 8.03E-13 
2.93 17.17 (DspMO2) 0.00039 
Neural tube 
defect 
0 16.33 (DspMO1) 2.31E-12 
1.46 15.02 (DspMO2) 4.91E-07 
Eye defect 
5.45 44.77 (DspMO1) 5.61E-07 
7.25 63.16 (DspMO2) 2.91E-12 
Fin defect 
1.82 53.23 (DspMO1) 6.79E-120 
0 38.16 (DspMO2) 9.65E-09 
Cardiac edema 
1.82 17.74 (DspMO1) 8.51E-89 
2.9 50 (DspMO2) 2.33E-10 
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Table 1.9: Prevalence of phenotypes in Dsp mutants with p-values. 
Phenotype Wild-type (%) Dsp Mutant (%) p-value 
Skin defect 0.78 
7.3 (DspCRISPR1) 0.00021 
8.18 (DspCRISPR2) 5.64E-05 
Blister 1.56 
10.95 (DspCRISPR1) 1.46E-05 
12.06 (DspCRISPR2) 2.83E-06 
Neural tube 
defect 
0 
5.48 (DspCRISPR1) 0.00015 
5.17 (DspCRISPR2) 0.00023 
Eye defect 1.41 
13.33 (DspCRISPR1) 1.62E-08 
8.05 (DspCRISPR2) 0.0015 
Fin defect 0.47 
9.09 (DspCRISPR1) 7.61E-09 
8.05 (DspCRISPR2) 0.00012 
Cardiac edema 0.47 
10.91 (DspCRISPR1) 4.08E-06 
8.05 (DspCRISPR2) 0.00012 
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Table 1.10: Percentage of junctions with desmosomes in CMO and DspMO1 morphants. 
Stage Embryo No. of 
junctions 
analyzed 
Percentage of junctions  
0 
desmosomes/ 
junction 
1 
desmosome/ 
junction 
2 
desmosomes/ 
junction 
N≥3 
desmosomes/ 
junction 
CMO 1 26 3.85  
(n=1) 
26.92 
(n=7) 
34.62 
(n=9) 
34.62 
(n=9) 
2 18 0 
(n=0) 
50 
(n=9) 
33.33 
(n=6) 
16.67 
(n=3) 
DspMO1 1 24 33.33 
(n=8) 
20.83 
(n=5) 
45.83 
(n=11) 
0 
(n=0) 
2 32 50 
(n=16) 
43.75 
(n=14) 
3.13 
(n=1) 
3.13 
(n=1) 
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SECTION 3: REGULATION OF CELL JUNCTION LOCALIZATION BY C-JUN N-
TERMINAL KINASE 
 
Previous studies have demonstrated that JNK signals regulate adherens junction assembly 
in cultured intestinal epithelial cells (Naydenov et al., 2009). JNK inhibition also protects against 
E-cadherin internalization by EGTA-mediated calcium depletion in Xenopus epidermis (Houssin 
et al., 2017). Therefore, the next step was to determine whether JNK also regulated desmosomal 
junctions. 
 
A.   INCREASED JNK ACTIVITY IS ASSOCIATED WITH LOSS OF DESMOPLAKIN  
First, the previously established constitutively-active JNK1 construct was injected into 
embryos to determine whether JNK signals regulate junctional disassembly in the Xenopus 
epidermis (Fig. 1.17A). This construct consists of a Mus musculus Map2k7β2 upstream of human 
JNK1α1. Map2k7 (MKK7) activates JNK1 in a constitutive manner (Lei et al., 2002; Liao et al., 
2006). Wild-type embryos at st. 30-31 (35-38 hpf) were used as controls. Results revealed that 
while controls had Dsp expression at the cell membrane, CA-JNK-expressing embryos had 
decreased desmoplakin at the cell edges (70%, n=17, 3 experiments, Fig. 1.17B,C).  Furthermore, 
desmoplakin appeared to be present in cytoplasmically- localized globules in a subset of cells in 
these embryos (Fig. 1.17C, arrows).  These results suggest the possibility that increased JNK 
activity reduces desmoplakin levels. 
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B. DECREASED JNK ACTIVITY DURING GASTRULA STAGES IS ASSOCIATED 
WITH INCREASED DESMOPLAKIN AT THE MEMBRANE 
Increased JNK activity was associated with reduced desmoplakin. Therefore, a plausib le 
hypothesis is that decreased JNK activity would have the opposite effect, i.e., an increase in 
junctional desmoplakin. 
To test this, embryos were treated with a JNK inhibitor, SP600125, at a concentration of 
100µM from st. 14 (26 hpf) until st. 19 (31 hpf) (Fig. 1.17D). Normally at st. 19, desmoplakin is 
punctate at the membrane. Results revealed that desmoplakin was increased in 72% of embryos 
treated with SP600125 relative to controls (n=25, 3 experiments) (Fig. 1.17E, F). These results 
suggest that decreased JNK activity might increase desmoplakin at the membrane. 
 
C. DECREASED JNK FUNCTION IS ASSOCIATED WITH RESISTANCE TO EGTA-
MEDIATED DISPLACEMENT OF JUNCTIONAL PROTEINS 
JNK inhibition was associated with increased desmoplakin at the junction. Also, inhibit ing 
JNK in cell culture and Xenopus embryos alleviated ethylene glycol-bis(β-aminoethyl ether)-
N,N,N',N'-tetraacetic acid (EGTA)-mediated internalization of E-cadherin (Houssin et al., 2017; 
Naydenov et al., 2009). EGTA chelates available calcium in the medium causing internaliza t ion 
of calcium-dependent junctions (Kartenbeck et al., 1991; Wallis et al., 2000). Therefore, the next 
step was to determine whether JNK inhibition could also alter EGTA-mediated displacement of 
desmoplakin in the Xenopus larval epidermis. 
To test this hypothesis, st. 32 embryos were treated with a JNK inhibitor (SP600125) until 
st.41 followed by a short EGTA (4mM) treatment (Fig. 1.18A). Results revealed that the epidermis 
of control embryos (treated with EGTA) began to dissociate from the rest of the body after an 
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average of 27 min. (Fig. 1.18D). On the other hand, embryos exposed to both the JNK inhib itor 
and EGTA took on average 63 min longer to begin to dissociate (n=16, 2 experiments; Fig. 1.18E; 
average time to begin dissociation=90 min.). 
Next, desmoplakin was imaged by immunofluorescence in treated embryos to determine 
whether there were changes in localization. Results revealed that in embryos treated with DMSO 
or SP600125 alone, desmoplakin was maintained at the membrane (Fig. 1.18F,G). In the embryos 
that only received EGTA, the desmoplakin appeared to be re-localized to the cytoplasm (n=16, 2 
experiments; Fig. 1.18H).  However, in embryos treated with both the JNK inhib itor and EGTA, 
the desmoplakin was maintained at the membrane similar to controls that were treated with DMSO 
or treated with SP600125 alone (n=16, 2 experiments; Fig. 1.18I). These results indicate that JNK 
inhibition can protect the cells from the anti-adhesive effects of EGTA. Furthermore, JNK 
inhibition appears to protect against the EGTA-mediated loss of adherens junction and desmosome 
components from the membrane. 
 
D. JNK INHIBITION ENHANCES THE MECHANICAL RESISTANCE OF 
DESMOPLAKIN MORPHANTS 
JNK inhibition prevented EGTA-induced displacement of desmoplakin and E-cadherin. 
Additionally, overexpression of E-cadherin can compensate for Pemphigus vulgaris IgG-mediated 
loss of desmosomal adhesion in cells (Rotzer et al., 2015), suggesting a role for E-cadherin in 
mechanical resistance. Therefore, the next step was to determine whether JNK inhibition of Dsp 
morphants improves the mechanical stress response. To test this, DspMO1 and control morphants 
were treated with the JNK inhibitor (100μM SP600125) or control (DMSO) for 5 hours (st. 22-
26).  The mechanical resistance of the SP600125- and DMSO-treated DspMO1 and control 
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morphants was evaluated using the “Impact Assay” (as described in section 2, Part III, A.1) (Fig. 
1.19A).  Results revealed that 77% of the DMSO-treated DspMO1 morphants had epidermal tears 
(n=24, 3 experiments) (Fig. 1.19D,F). On the other hand, only 33% of JNK inhibitor treated 
DspMO1 morphants had epidermal tears or disruptions (n= 21, 3 replicates, t-test, p= 0.005; Fig. 
1.19E,F). These results present the possibility that blocking JNK function can increase mechanica l 
resistance in the epidermis of desmoplakin-deficient embryos. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
92 
 
 
 
Figure 1.17: Differences in JNK activity is associated with changes in desmoplakin pattern 
at cell membranes. 
(A) Schematic of experimental design for injection of constitutively-active JNK1 (CA-JNK). (B-
C) IF of Dsp (red) in WT (B) and CA-JNK-injected embryos (C). Apparent cytoplasmical ly-
localized globules of Dsp in (C) (white arrows) (Scale bar = 25µm). (D) Schematic of experimenta l 
design for treatment of embryos with JNK inhibitor SP600125. DMSO is used as control treatment. 
(E-F) IF of Dsp (green) in DMSO- (E) and SP600125-treated embryos (F) (Scale bar = 25µm). 
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Figure 1.18: Decreased JNK activity is associated with resistance to EGTA-mediated 
internalization of junctional proteins. 
(A) Schematic of experimental design for treatment of embryos with JNK inhibitor SP600125 and 
EGTA. (B-E) Images of embryos after treatment with DMSO (B), SP600125 (C), DMSO+EGTA 
(D), and SP600125+EGTA (E). (F-I) IF of desmoplakin after treatment with DMSO (F), SP600125 
(H’), DMSO+EGTA (H), and SP600125+EGTA (I) (Scale bar = 50μm).  
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Figure 1.19: JNK inhibition enhances the mechanical resistance of desmoplakin morphants .  
(A) Schematic of treatment of embryos with JNK inhibitor SP600125 followed by mechanica l 
assay. (B-E) Images of embryos after mechanical assay of CMO+DMSO (B) CMO+SP600125 
(C), DspMO1+DMSO (D), and DspMO1+SP600125 (E) (Scale bar  = 1 mm). (F) Graph depicting 
proportion of embryos with damaged epidermis after mechanical assay. 
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DISCUSSION 
 
Diseases of the desmosome often result in abnormalities in the skin, heart, and hair follic le. 
This causes increased susceptibility to skin infections and cardiac disorders, the latter of which can 
be fatal during teenage years. One way to help affected individuals is by targeting signaling 
pathways that contribute to the pathophysiology of the disease. Hence, creating animal models of 
desmosomal disease can facilitate the study and development of therapeutic strategies. This study 
here uses antisense morpholinos and the CRISPR/ Cas9 system to reduce the levels of the 
desmosomal protein, desmoplakin, in Xenopus embryos. Abnormalities are present in the 
epidermis and desmosome ultrastructure already described in previous literature (Gallicano et al., 
2001). Furthermore, there are anomalies in the development of other embryonic structures such as 
the orofacial region. Perturbations in morphogenesis, including radial intercalation of distinct cell 
types into the outer layer of the developing epidermis also occur. Additionally, this study 
demonstrates a potential role for c-Jun N-terminal kinase (JNK) in regulating desmosome 
assembly in vivo. 
 
Desmosome structure and development is highly similar in the frog embryonic epidermis 
The desmosome structure in the Xenopus embryo is similar to other 
vertebrates.  Ultrastructurally, the desmosome appears as a distinct electron-dense cytoplasmic 
plaque adjacent to the plasma membrane (Berika and Garrod, 2014; Farquhar and Palade, 1963, 
1965). This structure is similar to desmosomes observed in the adult skin and tadpole of X. laevis 
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(Borysenko and Revel, 1973). Importantly, it also resembles those observed in humans, mice and 
zebrafish (Fleming et al., 1991; Garrod and Chidgey, 2008; Goonesinghe et al., 2012; Holbrook 
and Odland, 1975). Desmosomes in Xenopus embryos were infrequently observed to possess a 
“midline”. Midline-containing desmosomes are also observed as early as blastocyst stages in the 
mouse (Fleming et al., 1991). Such a midline is thought to indicate a mature desmosome. Evidence 
in mouse epidermis and tissue culture also suggests that such desmosomes might also be 
“hyperadhesive” (Garrod and Kimura, 2008; Garrod et al., 2005; Hobbs and Green, 2012). 
Hyperadhesive desmosomes are insensitive to calcium depletion, which is normally required for 
desmosomal cadherin dimerization. Tissue remodeling, which occurs frequently in a developing 
embryo, would require that some desmosomes be more dynamic and therefore, not hyperadhesive. 
This is indeed the case in the early mouse embryo which initially has calcium-dependent 
desmosomes that lack a midline. Desmosomes then develop a midline and become hyperadhesive 
between E12-E14. Hyperadhesive desmosomes can also revert to calcium-dependence in the 
mouse trophectoderm, which might be required to facilitate cell migration (Kimura et al., 2012). 
Thus, the presence of a hyperadhesive or mature desmosome in an early embryo might indicate 
the need for tissue stability at certain times during development.  
Consistent with the structural observations of Xenopus embryonic desmosomes, molecular 
studies indicate the presence of desmosomal cadherins in the epidermis of the X. laevis adult (Ohga 
et al., 2004). RNAseq analysis of the X. laevis transcriptome also reveals the expression of 
Desmoglein 2, Desmocollin 3, and Desmoplakin, in the embryo beginning in cleavage stages 
(Session et al., 2016). 
Not only does the Xenopus desmosome share structural similarities, it may also increase in 
numbers as the embryo develops across vertebrates. There was a quantitative increase in the 
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number of epidermal desmosomes per junction in the outer epidermal layers in the Xenopus 
embryo between gastrulation and neurulation. Similarly, in the mouse embryo, desmosome 
numbers per junction increase between the cleavage and blastocyst stages (Fleming et al., 1991). 
In the developing human epidermis, desmosome numbers increase between the 9th and 20th weeks 
of gestation (Dale et al., 1985; Holbrook and Odland, 1975). Although the observations in 
Xenopus, mouse, and human are recorded at different timepoints, this data indicates that there is 
an increase in desmosomal numbers per junction as the vertebrate embryo develops. This trend 
coincides with epidermal development in the Xenopus embryo. During this time, the ectoderm 
undergoes migratory movements such as convergent extension and radial intercalation and begins 
to express epidermal differentiation markers (Jonas et al., 1985; Nieuwkoop and Faber, 1967; 
Wilson and Hemmati-Brivanlou, 1995). Maintaining an adhesive outer layer while these dynamic 
processes occur is crucial. The vitelline membrane, which normally protects the embryo from 
external forces, is also gradually lost after neurulation as the embryo becomes increasingly motile. 
Thus, the increase in desmosomes might facilitate stronger intercellular binding to form an 
epidermis that has greater adhesion and protective capabilities. 
At later stages in the Xenopus embryo, desmosome numbers continued to increase and 
began to appear between inner and outer cell layers. During tadpole stages, desmosomes are 
present between cells within the inner layer. Similarly, such findings are reported in the developing 
human fetal epidermis (Dale et al., 1985; Holbrook and Odland, 1975). Specifically, desmosomes 
are observed between the periderm and basal layers of the developing epidermis. As the huma n 
epidermis undergoes stratification beginning at the 9th gestational week, desmosomes begin to 
appear between the new layers as well (Dale et al., 1985). Thus, the appearance of these 
desmosomes may serve to further strengthen the epidermal tissue. 
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Together, the similarity in desmosome structure and development between Xenopus and 
mammalian models indicate that the frog is a practical model for the study of desmosomes in the 
embryo. 
 
The Xenopus desmoplakin gene and protein are highly similar to mammalian homologs  
Our analysis revealed that desmoplakin, a component that is unique to and present in all 
desmosomes, is highly similar between Xenopus and mammalian homologs. The Xenopus dsp.L 
coding region contains 24 exons similar to the human and mouse homologs (Green et al., 1999). 
The Xenopus Dsp.L protein also shares a high degree of similarity with mouse and human 
homologs. Furthermore, the three functional domains of Dsp, the plakin, rod, and C-terminal were 
predicted to be present and shared a high degree of similarity with the corresponding domains in 
mammalian Dsp. Thus, the high degree of similarity between Xenopus and mammalian 
desmoplakin at the whole protein and domain level suggests that function might also be conserved 
across species. This further validates the frog model as an ideal model for the study of 
desmoplakin. 
 
The Xenopus desmoplakin L and S homologs are highly similar except in the plakin domain 
Genome annotation in X. laevis reveals the presence of Dsp on each subgenome, Dsp.L 
and Dsp.S. Comparative analysis revealed a high degree of similarity between the domains of 
Dsp.L and Dsp.S homologs. However, while the dsp.L and dsp.S gene coding regions share 91% 
identity, the coding region of dsp.S only contains 22 exons, where the missing exons correspond 
to exons 11 and 12 in dsp.L. Closer inspection of the individual domains revealed differences in 
the SR56/ SH3 plakin subdomains. This region corresponds to the missing exons in dsp.S. Further, 
 
 
99 
 
RNAseq data reveals that both homologs are differentially expressed in the embryonic stages as 
well as adult tissues (Session et al., 2016). Dsp.S has relatively higher expression until the gastrula 
stages (st. 10) and this pattern reverses at neurulation stages (st. 15). In adult tissues, both homologs 
are expressed in the skin, eye and heart tissues, although at differing levels. The high degree of 
similarity between the homologs suggests that the differential expression patterns might only 
persist as an ancestral mechanism that was not subject to selection. However, the expression of 
both Dsp homologs simultaneously suggests an overall higher gene dosage requirement.  
Investigating the mechanism of transcriptional regulation of each homolog might provide insight 
into differences in expression. Although not analyzed in this study, only one of the two Dsp 
morpholinos was predicted to target both the Dsp.L and Dsp.S mRNA, while the other is predicted 
to target only Dsp.L. This is based on the number of mismatches between the morpholino and the 
homolog. Therefore, it might be expected that targeting both homologs might have a more 
detrimental effect than if only one homolog was targeted. Both Dsp morphants present with the 
same phenotypes with similar severities, suggesting that 1) Dsp.L is the major homolog expressed 
with minimal contribution from Dsp.S or 2) both homologs are targeted by the morpholino even 
though one is not predicted to be targeted. One way to confirm this is to perform a qRT-PCR of 
the Dsp.S mRNA in both morphants. Alternatively, designing morpholinos that are can bind to 
homolog-specific regions can tease apart the relative importance of each homolog. 
 
Deficient desmoplakin in X. laevis results in defects in epidermis and the heart 
The desmoplakin morphant and F0 mutant Xenopus embryos were able to progress through 
gastrulation without any apparent defects, similar to the Dsp knockout mouse (Gallicano et al., 
2001). Also comparable to mouse embryos lacking desmoplakin, defects became apparent after 
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this stage. This coincides with the increase in desmosome number, suggesting that desmoplakin 
and desmosomes might have a more significant role post-gastrulation. 
The most distinct phenotype in Xenopus Dsp morphants and mutants was the smaller size 
of the embryos. Mouse embryos lacking Dsp are also smaller (Gallicano et al., 2001). There are 
several possibilities to explain the small size observed here. Preliminary data reveals a reduction 
in cell division in the Xenopus Dsp morphants. A similar reduction in cell proliferation is reported 
in the Dsp knockout mouse embryos (Gallicano et al., 2001). Smaller size could also be caused by 
an increase in cell death in the embryo. However, while it was not determined whether Xenopus 
embryos deficient in Dsp have increased cell death, no significant increase in apoptotic cells is 
observed in the Dsp knockout mouse (Gallicano et al., 2001). Epidermal cell surface areas in 
Xenopus Dsp morphants were smaller which could also account for a smaller size of the embryo. 
Convergent extension, which facilitates expansion of the surface area in the developing embryo 
and elongation along the anterio-posterior axis is partially regulated by cell adhesion (Shimizu et 
al., 2005; Solnica-Krezel et al., 1996; Walck-Shannon and Hardin, 2014). For example, when 
desmosomal cadherins Desmocollin 1 and Desmoglein 2 are decreased in zebrafish, convergent 
extension movements are defective, resulting in reduced anterio-posterior axis length 
(Goonesinghe et al., 2012). Therefore, perturbations in this process may also occur as a result of 
reduced desmoplakin. Finally, a failure of all the above processes in combination might culminate 
in smaller embryo size in Dsp morphants. 
Xenopus Dsp morphants and mutants also exhibited epidermal blistering. Such blistering 
is also documented in plakoglobin- and epidermis-specific Desmocollin 3-knockout mouse models 
as well as patients with desmosomal diseases such as pemphigus (Bierkamp et al., 1996; Chen et 
al., 2008; Mahoney et al., 1999; Payne et al., 2004). Blistering can occur as a result of loss of 
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keratinocyte adhesion or acantholysis. Therefore, reduction of Dsp in Xenopus embryos exhibit 
blisters probably due to impaired adhesion between cell layers. 
The skin of Xenopus embryos lacking Dsp was more fragile to mechanical perturbations 
such as impact and shear forces. Such fragility is also present in human patients with desmosomal 
diseases such as ectodermal dysplasia and skin fragility syndrome, which is caused by Plakophilin-
1 mutations (Jonkman et al., 2005; McGrath et al., 1997; Whittock et al., 2002). Additiona lly, 
mouse knockout models of plakoglobin, desmoglein 3, and desmocollin 1 exhibit epidermal 
fragility (Allen et al., 1996; Bierkamp et al., 1996; Chidgey et al., 2001). Also, loss of desmoplakin 
in mice can result in intercellular separation of epidermal layers and fragility to handling 
(Gallicano et al., 2001; Vasioukhin et al., 2001). Therefore, this suggests that the sensitivity of the 
Xenopus epidermis to mechanical forces might be a result of impaired desmosomal function which 
also mimics mammalian models. 
Cardiac defects were also present in Xenopus Dsp morphants and mutants. Such defects 
are a prominent clinical feature of disorders of desmosomal proteins, including  desmoplakin, 
plakoglobin, plakophilin 2, desmoglein 2, and desmocollin 2 (Awad et al., 2006; Beffagna et al., 
2007; Gerull et al., 2004; McKoy et al., 2000; Norgett et al., 2000; Pilichou et al., 2006; van 
Tintelen et al., 2006; Yu et al., 2008). The Dsp knockout mouse also has a collapsed heart with a 
relatively low heart rate (Gallicano et al., 2001). Overall, the similarities in defects further validates 
the applicability of the frog model for studies of the desmosome. 
Besides the common phenotypes associated with desmosome disruption, such as epidermal 
blistering or tearing and cardiac defects, other less common defects including hyperpigmentat ion, 
neural tube and eye defects also occur in Xenopus Dsp morphants and mutants. 
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Xenopus Dsp morphants and F0 mutants exhibited darkened patches of epidermis or 
hyperpigmentation. In animal models, melanin-containing melanosomes which influence 
epidermal pigmentation are known to be translocated by actin cytoskeleton and intermed iate 
filaments (Mayerson and Brumbaugh, 1981; Wasmeier et al., 2008; Wu et al., 1998). Actin and 
microtubules are also involved in melanosome movement in Xenopus melanophores (Rogers and 
Gelfand, 1998; Tuma et al., 1998). Here, keratin filaments appeared to be disrupted in Xenopus 
Dsp morphants. A similar disruption of these filaments is observed in patients with epidermolys is 
bullosa simplex with mottled hyperpigmentation caused by mutations in Keratin 5 (KRT5) 
(OMIM:131960) (Bruckner-Tuderman et al., 1989; Uttam et al., 1996). Ultrastructural analysis of 
hyperpigmented tissue in these patients reveals a perinuclear aggregation of melanosomes (Irvine 
et al., 2001). While it was not determined whether melanosome aggregation occurs in Dsp 
morphants, this suggests the possibility that disruption of the desmosome-keratin attachment or 
changes in actin organization indirectly might affect distribution of melanosomes within cells. 
Neural tube defects were observed in Xenopus Dsp morphants and mutants. In mice lacking 
Dsp, neural tube defects were also reported (Gallicano et al., 2001). Notably, no human cases of 
neural tube closure defects have been associated with defective desmosomes, although this might 
be because of embryonic lethality.  
Eye defects including abnormal RPE pigmentation were also present in Xenopus Dsp 
morphants and mutants. Dsp was detected in the Xenopus larval outer corneal 
epithelium.  Similarly, in the bovine, Dsp is detected in the corneal epithelium (Messent et al., 
2000). Further, desmosomes persist at the corneal wound edge in vitro in rabbits (Kuwabara et al., 
1976). Pemphigus vulgaris patients with anti-Dsg3 antibodies also have severe blistering of eyelid 
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conjunctiva (Lifshitz et al., 2004). Together these results suggest that desmosomes are required in 
the eye and that Dsp may play a role in the proper development of eye structures. 
 
Xenopus Dsp morphants have reduction in desmosomes and changes in tissue architecture  
A reduction in desmosomes per junction was observed in Xenopus embryos with deficient 
Dsp. Further, 43% of junctions had no desmosomes. A similar reduction in size and number of 
desmosomes is also reported in Dsp knockout mice (Gallicano et al., 1998). The intercellular gap 
between cells in Xenopus Dsp morphants was also increased at junctions with few or no 
desmosomes. In Dsp knockout mice also, there is a loss of adherence between cells (Gallicano et 
al., 2001). Similarly, zebrafish Desmocollin 1 and Desmoglein 2 morphants have an increase in 
intercellular gap when desmosomes are defective or absent (Goonesinghe et al., 2012). Therefore, 
these results suggest that desmoplakin might be essential for desmosome assembly or stability. 
However, an epidermis-specific Dsp knockout mouse displays no significant reduction in 
desmosome number in suprabasal layers, although keratin filament attachment is still perturbed 
(Vasioukhin et al., 2001). This might warrant further study to determine if desmoplakin acts as a 
desmosome reinforcer further in development. 
 
Xenopus embryos with deficient Dsp have defects in specialized cell types  
Cell types such as multiciliated cells, small secretory cells, and ionocytes are specified and 
intercalate into the outer epidermal layer in Xenopus larvae beginning sometime after gastrulat ion 
(Dubaissi et al., 2014). These cells are thought to contribute to the protection of the larva against 
bacterial infections (Stubbs et al., 2006). Xenopus embryos with deficient Dsp exhibited a decrease 
in the number of cilia-positive multiciliated cells and PNA-positive small secretory cells. When 
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cilia were present, they were shorter and fewer in number. The defective structures in these cell 
types indicate that differentiation might be perturbed when Dsp is reduced. The development of 
these cell types is controlled by many proteins. Forkhead transcription factors, Foxa1 and Foxj1 
are involved in the differentiation of small secretory cells and multiciliated cells, respectively 
(Dubaissi et al., 2014; Stubbs et al., 2008). Other transcriptional regulators such as multicilin and 
its upstream regulator Gmnc are necessary for expression of ciliogenesis genes such as α-tubulin 
(Stubbs et al., 2012; Zhou et al., 2015). Further, the planar cell polarity protein, Dishevelled, can 
regulate the docking of basal bodies which is required prior to extension of cilia (Park et al., 2008). 
However, there is no reported role for Dsp or desmosomes in multiciliated cell differentiat ion. 
Instead, Dsp may indirectly regulate basal body docking and ciliogenesis. For instance, loss of the 
basal body protein ninein results in impaired primary cilia formation in U2OS human 
osteosarcoma cells (Graser et al., 2007). Microtubule organization through ninein can, in turn, be 
regulated by Dsp in epidermal keratinocytes (Lechler and Fuchs, 2007). Thus, although basal body 
generation differs between  monociliated cells (such as primary cilia) and multiciliated cells  
(Brooks and Wallingford, 2014), Dsp may influence ciliogenesis in these cell types indirect ly. 
Together, these results suggest that Dsp may play a role in differentiation of these cell types by 
regulating the development of specialized structures.  
 
Desmosomes may play a novel role in radial intercalation 
 Here, multiciliated cells and small secretory cells were identified based on the expression 
of a single marker for each cell type. Since a second marker was not used to confirm these results, 
two main possibilities might explain these findings: 1) cells emerge but differentiation of these 
cell types is perturbed, and 2) the emergence of cells from the inner layer is disrupted. The 
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emergence of specialized cell types occurs through the process of radial intercalation (Deblandre 
et al., 1999; Dubaissi and Papalopulu, 2011; Dubaissi et al., 2014). Therefore, a plausible 
hypothesis is that radial intercalation is perturbed in embryos with deficient Dsp. Biotin labeling 
assays confirmed that radial intercalation was slightly but significantly reduced in Xenopus Dsp 
morphants. 
Regulation of cell-cell and cell-extracellular matrix interactions can influence radial 
intercalation (Walck-Shannon and Hardin, 2014). For example, cell-ECM interactions through 
dystroglycan are required for radial intercalation to occur in the X. laevis epidermis (Sirour et al., 
2011). Inhibition of the Epidermal Growth Factor pathway leads to defects in E-cadherin turnover 
and is correlated with reduced intercalation in the zebrafish blastoderm during epiboly (Morita and 
Heisenberg, 2013; Song et al., 2013). There is also some evidence for proteins that regulate planar 
cell polarity in this process. For instance, Par3 and Par6 are required for apical positioning of 
CLAMP in intercalating cells of X. laevis epidermis. In turn, CLAMP promotes microtubule 
stabilization, which is thought to be required for intercalation (Werner et al., 2014). Loss of 
function of another PCP protein, the Rab11 GTPase, results in defects in establishment of the 
apical domain of multiciliated cells and, in turn, intercalation in X. laevis epidermis (Kim et al., 
2012). The results of this study suggest a possible role for desmoplakin in facilitating radial 
intercalation. 
Radial intercalation culminates when emerging cells “dock” in the outer layer. This is 
followed by expansion of the apical surfaces of these cells. Xenopus embryos deficient in Dsp have 
a significant reduction in apical surface area of intercalating cells. Occasionally, cilia-positive and 
PNA-positive cells were detected in Xenopus Dsp morphants. However, these cells were situated 
below the apical surface, appearing to be “stuck” between the two layers (data not shown). 
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Together, these results suggest a problem with both apical emergence and expansion. The resulting 
defective apical expansion could explain why cells have fewer cilia (in MCCs) or vesicles (in 
SSCs). The decrease in apical surface area might prevent basal body or vesicle docking at the 
apical membrane resulting in defective development of these structures. 
Two of the three major cytoskeletal filaments, actin and microtubules, are implicated as 
drivers of emergence and apical expansion in the Xenopus epidermis. These processes are partly 
governed by cell-autonomous RhoA- and formin1-mediated actomyosin tractive forces through E-
cadherin (Sedzinski et al., 2016, 2017). Further, CLAMP-mediated stabilization of microtubules 
at the apical region of intercalating cells is required for radial intercalation (Werner et al., 2014). 
The current study reveals that keratin filaments are disorganized in Xenopus embryos with 
deficient Dsp. Therefore, it is possible that intermediate filaments, which constitute the third major 
cytoskeletal protein might also be involved in emergence and apical expansion of intercala t ing 
cells. However, further experiments will have to be performed to determine whether this is the 
case. 
In summary, there are two possible mechanisms through which radial intercalation is 
regulated by the desmosomal complex. First, desmosomal adhesion might be necessary for traction 
forces, which are found to be important for this process. Therefore, the loss of desmosomal 
complex from cell contacts when desmoplakin is reduced possibly abrogates this tractive force 
required for radial intercalation and expansion. Second, tractive forces through the keratin 
filaments might also be crucial. Therefore, the disorganization of keratin filaments observed in 
desmoplakin morphants might result in a reduction in transmission of these forces within the 
intercalating cell (Fig. 1.20).  
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C-Jun N-terminal Kinase (JNK) is a potential regulator of desmoplakin localization and 
stability 
Altering JNK signaling was correlated with changes in desmoplakin localization in 
Xenopus embryos. JNK (c-jun N-terminal kinase), a MAPK protein, is activated by exposure of 
cells to stressors including osmotic stress and radiation (Ip and Davis, 1998; Rosette and Karin, 
1996). It regulates a wide variety of cellular processes including apoptosis, migration, and cell 
division (Davis, 2000; Dong et al., 2001; Karin and Gallagher, 2005). JNK can also regulate 
morphogenesis in the embryo, such as convergent extension movements (Kuhl, 2002); (Yamanaka 
et al., 2002). JNK is also known to regulate cell junction proteins. Constitutively-active JNK1 
disrupts E-cadherin organization at cell contacts in Xenopus embryos (Houssin et al., 2017). 
Cytoplasmic puncta of E-cadherin are also observed in these embryos in conjunction with 
membrane-localized clathrin, suggesting endocytosis in response to JNK activity. Additiona lly, 
increased JNK activity is associated with disruption of adherens and tight junction proteins in 
different epithelial cell types (Naydenov et al., 2009; Samak et al., 2011; You et al., 2013).  
In the current study, several experiments reveal a correlation between JNK activity and 
desmoplakin localization and adhesion. First, increased JNK activity was found to be correlated 
with reduced membrane desmoplakin in Xenopus embryonic epidermis. Cytosolic clusters of 
desmoplakin were also present in these embryos. Conversely, inhibiting JNK in the neurula t ing 
Xenopus embryo was associated with increased desmoplakin at cell contracts relative to controls.  
Second, inhibition of JNK protected against cytosolic displacement of desmoplakin in the 
presence of EGTA, a calcium chelator. The EGTA-induced desmoplakin dissociation assay is used 
to demonstrate the occurrence of hyperadhesion or calcium-independent adhesion (Garrod et al., 
2005; Mattey and Garrod, 1986; Wallis et al., 2000). Following JNK inhibition, there is resistance 
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to EGTA-mediated internalization of E-cadherin in Xenopus embryonic epidermis (Houssin et al., 
2017). Naydenov and colleagues (2009) also demonstrate an increase in phospho-JNK (active 
JNK) following calcium depletion, further suggesting this increase in active JNK as a mechanism 
for EGTA-mediated loss of desmosome adhesion. Post-translational modification of desmosomal 
proteins might influence stability or adhesion. For instance, phosphorylation of Dsp at specific 
serine residues is associated with desmosome disassembly or loss of hyperadhesion (Dehner et al., 
2014; Kroger et al., 2013). This phenomenon is found to occur in a Protein Kinase C alpha (PKCα)-
dependent manner, although a direct interaction is yet to be demonstrated (Bass-Zubek et al., 2008; 
Godsel et al., 2005; Hobbs and Green, 2012; Kroger et al., 2013; Sheu et al., 1989). Furthermore, 
PKCα is an established regulator of desmosomal hyperadhesion in confluent cell culture and 
wound edge epidermis (Garrod and Chidgey, 2008; Garrod et al., 2005; Wallis et al., 2000). 
Similarly, JNK can also regulate cell adhesion and migration by phosphorylating cell junction 
proteins including β-catenin and focal adhesion protein paxillin, respectively (Huang et al., 2003; 
Lee et al., 2009). Therefore, JNK might regulate desmosomal hyperadhesion directly or indirect ly 
through phosphorylation of desmosomal proteins.  
Third, the epidermis of Xenopus Dsp morphants displays increased resistance to 
mechanical stress following JNK inhibition. Previous data reveals maintenance of adhesion against 
EGTA-mediated calcium depletion in Xenopus embryos following treatment with a JNK inhib itor 
(Houssin et al., 2017). E-cadherin is also not internalized in these embryos. Since the JNK pathway 
is known to be involved in mechanotransduction, it is possible that JNK signaling might affect the 
mechanical response of Xenopus Dsp morphants. For example, mechanical stretching can activate 
JNK in multiple cell types in vitro (Ingram et al., 2000; Katsumi et al., 2005; Pereira et al., 2011). 
Mechanically-activated JNK can further lead to cellular and morphological effects such as actin 
 
 
109 
 
remodeling in endothelial cells and enhanced migration in human mesenchymal stem cells 
(Mengistu et al., 2011; Yuan et al., 2012). Activation of JNK through mechanotransductive signals 
can also induce osteoblast apoptosis (Matsui et al., 2014). However, the response of JNK to 
mechanotransduction in these instances occurs over minutes or hours. The mechanical assays 
performed here are virtually instantaneous, making it implausible that JNK-mediated increase in 
adhesion is due to rapid modifications of desmosomal proteins. Instead, the inhibition of JNK 
during the treatment phase might modify desmosomal adhesion. Dsp morphants still form some 
desmosomes at cell-cell junctions. Preliminary data also reveals that E-cadherin is present at the 
membrane in Dsp morphants but may be reduced. Therefore, JNK inhibition in Dsp morphants 
might increase resistance to mechanical forces by strengthening adhesive contacts at existing 
desmosomes and adherens junctions. 
There are a number of plausible mechanisms through which JNK might be regulat ing 
desmosome assembly or stability. First, JNK may directly interact with and phosphorylate 
desmosomal or desmosome-associated proteins, leading to conformational changes and 
disassembly. JNK phosphorylates the armadillo protein β-catenin leading to disruption of the 
adherens junction (Lee et al., 2009; You et al., 2013). The adherens junctions and desmosomes are 
analogous to each other since both junctions contain members of the cadherin and armadillo 
protein families. For example, desmosomes contain plakoglobin, a member of the armadillo family 
most closely related to β-catenin (Peifer et al., 1992). Further, plakoglobin has overlapping 
functions with β-catenin, being able to interact with the same molecules (Zhurinsky et al., 2000). 
Plakoglobin is also able to interact with Tcf/ Lef proteins, a β-catenin target in the canonical Wnt 
signaling pathway (Kolly et al., 2007; Williamson et al., 2006). Therefore, plakoglobin might be 
a hypothetical target for JNK phosphorylation in the desmosome. JNK phosphorylates β-catenin 
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at the Ser37 and Thr41 residues (Lee et al., 2009; You et al., 2013). Both residues appear to be 
conserved in plakoglobin as well, further suggesting that plakoglobin is a putative JNK target. JNK 
also associates with the underlying intermediate filaments. JNK can phosphorylate keratin 8 
leading to intermediate filament reorganization (He et al., 2002; Park et al., 2011). Thus, a 
plausible hypothesis is that JNK phosphorylates plakoglobin or keratin (or both) leading to 
desmosome disruption. 
Second, JNK might regulate desmosome assembly through a transcriptional mechanism. 
In the current study, the JNK inhibition and activation paradigms were performed over many hours 
or days. Therefore, it is possible that changes in desmoplakin localization observed are due to 
JNK-mediated transcription. Inhibition of JNK in human epidermal keratinocytes over 48h leads 
to over 2-fold transcriptional induction of desmosomal genes of suprabasal cells includ ing 
Desmoglein 1 and Desmocollin 1 (Gazel et al., 2006). Also, JNK inhibition in HaCaT 
keratinocytes alters expression of basal epidermal markers Keratin 5, Keratin 17, and Desmogle in 
3 (Kitagawa et al., 2014). However, while changes to desmoplakin expression were not 
investigated here, a microarray of JNK-inhibited Xenopus embryos did not reveal deregulation of 
expression of any desmosomal genes. This suggests that JNK might differentially regulate 
transcriptional control of desmosomal genes in different stages of development or different 
models. 
Third, JNK activity might also regulate desmosome assembly indirectly through the 
adherens junction. As mentioned above, inhibiting JNK activity leads to adherens junction 
formation in many epithelial cell types (Naydenov et al., 2009; Samak et al., 2011; You et al., 
2013). There is also evidence to suggest that adherens junctions formation is a prerequisite to 
desmosome formation. For instance, disruption of adherens junctions and classical cadherins delay 
 
 
111 
 
desmosome assembly in keratinocytes and other epithelial cell types, although a detailed 
mechanism is yet to be determined (Amagai et al., 1995a; Gumbiner et al., 1988). Therefore, JNK 
activity might regulate desmosome formation indirectly through its effects on adherens junction 
formation. 
Fourth, JNK might regulate desmosome assembly though an endocytic mechanism. Upon 
injection of constitutively-active JNK1 in Xenopus embryos, there is an increase in membrane-
localized clathrin (Houssin et al., 2017). JNK might also remodel actin filaments near the 
membrane through activation of the ezrin-radixin-moesin complex, which associates with 
epithelial junctions (Ivanov et al., 2004b; Naydenov et al., 2009). Actin filament remodeling into 
contractile F-actin rings is known to be required for endocytosis of epithelial junctions (Ivanov et 
al., 2004a). While there are no direct JNK targets reported in this process, other MAPK proteins 
have been shown to be involved in junction endocytosis. For instance, p38MAPK inhibit ion 
prevents Pemphigus vulgaris IgG-mediated endocytosis of Dsg3 in keratinocytes (Jolly et al., 
2010). Moreover, this endocytosis is thought to occur through a caveolin-1-dependent mechanism 
(Delva et al., 2008). Therefore, JNK might regulate desmosome assembly dynamics through 
control of the endocytic pathway. 
In summary, there are many direct and indirect mechanisms through which JNK activity 
might regulate desmosome assembly. Based on what is known about JNK-mediated assembly of 
the tight and adherens junctions as well as interaction with keratin filaments, it is likely that the 
JNK-mediated phosphorylation of desmosomal proteins, for example, plakoglobin, regulates 
desmosome assembly (Fig. 1.21). On the other hand, JNK activity might also regulate desmosomal 
gene expression based on evidence of this pathway occurring in mammalian tissues (Fig. 1.22). 
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CONCLUSIONS AND FUTURE DIRECTIONS 
 
The current study reveals roles for the desmosomal protein, desmoplakin, in the embryonic 
epidermis using the Xenopus laevis model. In addition to phenotypes commonly observed with 
desmosomal disruption, there are defects in neural tube closure and improper development of eye 
structures. There is evidence for the presence of junctional desmosomes in these tissues. This 
suggests that desmosomes are important for the morphogenesis of these tissues in the developing 
embryo. Knowledge of fate maps in the Xenopus embryo makes it a convenient model to alter the 
expression of desmoplakin (or other desmosomal proteins) in a tissue-specific manner. This 
method is one way to determine the function of desmoplakin in specific tissues. Such experiments 
can verify whether some of the phenotypes observed in this study are a consequence of 1) loss of 
desmoplakin function in the developing tissue itself or, 2) a non-specific effect due to disruption 
of an earlier developmental process. 
The results of the present study also reveal a relationship between desmosomes and radial 
intercalation in the epidermis. Specifically, there are perturbations in both radial intercalation and 
apical expansion when desmoplakin is reduced. Loss of desmosome from the cell contacts might 
1) enhance the ability of cells to intercalate due to less resistance, or 2) hinder the process due to 
less traction. The defective apical expansion might disrupt the final stages of differentiation and 
development of specialized structures. Assembly of actin and microtubule cytoskeletal filaments 
are thought to partially regulate radial intercalation, implying that keratin filaments might also play 
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a role (Sedzinski et al., 2016, 2017; Werner et al., 2014). Together, Dsp localization and Dsp-
mediated linkage of keratin might act as mediators of radial intercalation (Fig. 1.20).  
It is unknown whether Dsp and keratin attachment are required cell-autonomously or in the 
neighboring cells to facilitate apical expansion. One way to test this is to perform donor transplants 
of the outer epidermal layer prior to intercalation. This method involves removing the outer 
epidermal layer of a desmoplakin morphant and replacing the outer epidermal layer of the “host” 
control embryo or vice-versa. If desmoplakin or the desmoplakin- intermediate filament attachment 
is required in the outer layer for intercalation, then donor transplants that have reduced 
desmoplakin would exhibit reduced intercalation. If desmoplakin is required in the intercala t ing 
cell, then host embryos that have reduced desmoplakin would exhibit reduced intercalat ion. 
Desmoplakin may also be required for proper organization of actin or microtubules which, in turn, 
are known to be required for radial intercalation. Desmoplakin serves as a microtubule organizing 
center in differentiated keratinocytes (Lechler and Fuchs, 2007). Desmoplakin loss is also 
correlated with changes in actin cytoskeleton organization (Sumigray and Lechler, 2012; 
Vasioukhin et al., 2001). In addition, disruption of the desmosomal complex in Dsp morphants 
may lead to mislocalization of plakophilin 1, which is involved in actin cytoskeleton dynamics 
(Hatzfeld et al., 2000). To determine whether actin or microtubule organization is affected, 
immunofluorescence labelling of either filament can be performed. 
 Finally, data from this study highlights JNK as a possible regulator of desmosome 
assembly and adhesion. Phosphorylation and other post-translational modifications of junctiona l 
proteins is associated with control of junction assembly and adhesive strength. Alternatively, JNK 
might regulate desmosome assembly through a transcriptional pathway. Junction remodeling is 
crucial in tissues undergoing dynamic processes including morphogenesis, wound healing, and 
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cell division (Garrod et al., 2005; Higashi et al., 2016; Thomason et al., 2012). Indeed, JNK activity 
is high in the proliferating basal layer and relatively lower in differentiated suprabasal layers of 
human neonatal foreskin epidermis (You et al., 2013). Collectively, there are at least two plausible 
mechanisms through which JNK might regulate desmosome assembly and adhesion (Fig. 1.21, 
1.22).  
It is not yet known whether JNK interacts with desmosomal proteins as it does with proteins 
in the adherens and tight junctions. Performing a Co-IP and mass spectrometry of proteins that 
associate with JNK might give some insight into interactions. One caveat is the insoluble nature 
of the desmosomal plaque. This characteristic makes it difficult to separate the desmosomal 
proteins and therefore, study protein-protein interactions. However, new tools such as the biotin 
ligase-based BioID can be utilized to screen for possible protein-protein interactions (Roux et al., 
2013).  For example, a fusion protein of biotin ligase with JNK can be injected into embryos. 
Performing a capture of biotinylated proteins in these embryos followed by mass spectrometry can 
reveal if desmosomal proteins interact with JNK. If JNK-mediated phosphorylation of plakoglobin 
leads to changes in desmosome assembly dynamics, a phospho-deficient mutant of plakoglobin 
can be used. An expected result would be that overexpression of JNK would not affect desmosome 
assembly. Alternatively, a JNK in vitro kinase assay can be performed with plakoglobin as a 
substrate, which can then be analyzed for phosphorylation using mass spectrometry. 
If JNK exerts direct transcriptional control, a ChIP-Seq can be performed following 
treatment to determine whether cJun or the AP-1 complex are bound to promoter sequences. If 
there are changes in the level of binding to desmosomal genes, it would suggest that JNK 
transcriptionally regulates these loci. Alternatively, a bioinformatics analysis of promoter 
sequences can be performed to identify consensus binding sites for cJun or the AP-1 complex. 
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The assay to test for hyperadhesion also suggests that inhibiting JNK improves the 
adhesiveness of the desmosomal complex. Specifically, inhibiting JNK might lead to 
conformational changes in the calcium-binding domain of the desmoglein or desmocollins (Fig. 
1.23). One way to test this hypothesis is to image desmosomes using TEM to determine if there 
are more desmosomes with a midline, which is thought to represent a hyperadhesive desmosome. 
Since altering JNK activity has effects on desmosomal assembly and adhesion, it might 
influence radial intercalation as well. For instance, one plausible hypothesis is that overexpression 
of JNK leads to reduced intercalation due to reduction in desmoplakin at cell contacts. 
The results of this study have possible applications in treating human desmosomal disease. 
For example, inhibition p38MAPK alleviates some of the pathogenic effects of Pemphigus 
Vulgaris IgG in tissue culture, such as endocytosis of Desmoglein 3 (Saito et al., 2012). A plausible 
hypothesis is that inhibition of JNK might also prevent Desmoglein 3 internalization, similar to 
the effects observed in Xenopus epidermis. 
 In conclusion, the present study validates the use of the frog as a tractable model for the 
study of desmosomes. The study also demonstrates potential functions for desmoplakin and 
desmosomes in regulating epidermal morphogenesis and radial intercalation in the embryo. 
Finally, JNK is identified as a potential regulator of desmosome assembly and adhesion. This 
implicates JNK as a new therapeutic target in desmosomal disease treatment. Further investiga t ion 
into the mechanism of JNK-mediated regulation of the desmosome might reveal its efficacy in 
treating human disease.  
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Figure 1.20: Desmoplakin is a potential mediator of radial intercalation. 
(A) Radial intercalation in a normal embryo occurs through a step-wise process of apical 
emergence followed by apical expansion and development of specialized characteristics such as 
cilia in a multiciliated cell. This probably occurs through enrichment of Dsp. (B) Radial 
intercalation in embryos with deficient Dsp is faulty, possibly due to defective apical emergence 
and expansion, leading to smaller apical surface and defective development of specialized 
structures such as fewer and shorter cilia. 
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Figure 1.21: Model for JNK-mediated regulation of desmosome assembly through post-
translational modification. 
(A) A desmosomal complex at the cell-cell junction. (B, C) Increased JNK activity might lead to 
direct or indirect phosphorylation of desmosomal proteins such as plakoglobin (Pg) and keratin 
filaments. (D) Phosphorylation probably leads to keratin detachment and internalization of 
desmosomal components. 
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Figure 1.22: Model for JNK-mediated regulation of desmosome assembly through 
transcriptional changes. 
(A) Increased JNK activity might lead to reduced expression of desmosomal genes such as 
desmoglein (Dsg), desmocollin (Dsc), plakoglobin (Pg), and desmoplakin (Dsp). (B) These 
changes in expression might reduce the number of desmosomes at cell contacts as the embryo 
develops. 
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Figure 1.23: Model for JNK-mediated regulation of desmosome hyperadhesion. 
(A) Exposure to EGTA triggers calcium chelation which results in loss of calcium-dependent 
binding. (B) Reducing JNK activity prior to EGTA-mediated calcium chelation protects the 
desmosome from internalization by probably leading to a more organized structure and calcium-
independence.   
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CHAPTER 2:FAST AND EFFICIENT CRISPR/ CAS9 DESIGN FOR GENERATION OF 
XENOPUS LAEVIS DESMOPLAKIN MUTANTS 
 
INTRODUCTION 
 
This protocol presents a method for the generation of desmoplakin (Dsp) mutants in Xenopus 
laevis. First, a gene-specific single guide RNA (sgRNA) was designed and synthesized as a double 
stranded DNA (dsDNA) template with an RNA polymerase binding site and loop sequence. This 
template was then transcribed into an oligo containing the sgRNA target site and loop sequence. 
Then, sgRNA along with Cas9 protein were injected into the embryo at an appropriate 
developmental stage based on whether whole embryo or tissue-specific targeting is required. DNA 
was then extracted from F0 mutants and analyzed with the T7 endonuclease I assay to determine 
if mutations were present. This protocol also describes methods to sequence the sgRNA target site 
to identify specific mutations. 
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RELATED INFORMATION 
 
Some methods described here are partially adapted from a protocol used for generating mutants in 
zebrafish (Danio rerio) (Shah et al., 2016). Additional considerations for efficient sgRNA design 
have been described elsewhere (Doench et al., 2016; Doench et al., 2014; Xu et al., 2015). 
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MATERIALS 
 
REAGENTS 
Agarose gel (3% [w/v] in 1X TAE buffer)  
Prepare as 1:1 ratio of regular agarose (1.5% [w/v]) and Super Fine Resolution agarose 
(1.5% [w/v]). This mix is easier to dissolve and has high resolution.  
Alkaline Lysis Buffer (1X)  
Prepare fresh from 50X stock (25mM NaOH, 0.2mM Na2+-EDTA). 
Cas9 protein  
Store at -80°C. 
Ethanol (70% [w/v], prepared in nuclease-free water) 
Lithium chloride precipitation solution  
Store at -20°C. 
MEGAscript T7 transcription kit  
Store at -20°C. 
Modified Barth’s Solution (MBS) (0.1X) 
Na2+-EDTA (0.25M) 
NEBuffer 2 (10X) 
Neutralization buffer (1X)   
Prepare fresh from 50X stock (40mM Tris-HCl). 
Nuclease-free water 
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PCR product purification kit 
Phusion PCR Master Mix  
Store at -20°C. 
 
Scaffold Oligo (PAGE purified) 
5’-
GATCCGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTA
ACTTGCTATTTCTAGCTCTAAAAC-3’ 
 
T7 endonuclease I (M0302, NEB) Store at -20°C.  
This is used to detect heteroduplex DNA resulting from CRISPR/ Cas9-mediated 
mutagenesis.  
 
Xenopus laevis embryos, stage of interest  
Embryo jelly coat must be removed completely prior to microinjection. See Dejellying 
Xenopus laevis Embryos (Sive et al., 2007) for more details. 
 
EQUIPMENT 
Dissecting or stereoscopic microscope 
Equipment for injecting Xenopus embryos  
see Microinjection of Xenopus Embryos (Sive et al., 2010). 
Forceps 
Freezer, -20°C and -80°C 
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Gloves, powder-free 
Incubator, 15-23°C 
Microcentrifuge 
Micropipettors, 2-, 20-, and 100-µl, with corresponding tips 
Microwave oven 
PCR tubes, 0.2ml, as needed 
Petri dishes, polystyrene 
Pipette pump  
Alternatively, a transfer pipette can be used. 
Spectrophotometer 
Thermal cycler, with Ramp function 
Tissue grinder or pestle (optional; see Step 22) 
Vortex mixer 
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METHOD 
 
A. DESIGN OF GENE- AND HOMOLOG-SPECIFIC sgRNA TEMPLATE 
 
1. Obtain coding sequence in the Xenopus laevis genome on Xenbase (xenbase.org).  
 
2. Determine if Dsp is present on the Long (L) and Short (S) chromosomes. 
 
X. laevis is an allotetraploid, therefore, there are subgenome homologs of Dsp on both the L and 
S chromosomes (Graf and Kobel, 1991; Session et al., 2016). This step helps in identifying 
conserved sequence motifs between both subgenome homologs. 
 
3. Ensure that exons in the coding region of all homologs are present. 
 
Creating mutations in exons can result in successful loss of function. Exons are also preferable 
because many X. laevis genes have incompletely sequenced introns (except when proximal to exon 
boundaries) making them unreliable targets. 
 
4. Use individual exons as targets in a prediction software and run the program to obtain the most 
efficient sgRNA(s) against a target region. 
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The CHOPCHOP tool was used to predict sgRNA targets in Xenopus 
laevis  (http://chopchop.cbu.uib.no/).The sgRNA sequence generated was a 23 bp oligonucleotide 
which includes a 3 bp NGG protospacer-adjacent motif (PAM) at the 3’ end. The target region 
was chosen as close to the N-terminus or within well-characterized functional domains (Shi et al., 
2015a). In order of preference, the first two nucleotides of this sequence should be 
GG>GA=GT>GC for efficient transcription by T7 RNA polymerase (Milligan and Uhlenbeck, 
1989; Shah et al., 2015). Multiple sgRNAs each targeting different exonic regions were chosen. 
This ensures specificity of phenotypes (Shah et al., 2016). 
 
To target one subgenome homolog: 
i. Choose an sgRNA with >3nt mismatches between homologs, preferably within 8-12 base pairs 
proximal to the PAM site. 
 
Alternatively, choose a region not conserved between subgenome homologs. Greater than 5 
mismatches can increase off-target mutagenesis (Fu et al., 2013). Therefore, it is always important 
to determine off-target site binding (for example, by performing a BLAST search). 
 
To target both subgenome homologs: 
ii. Choose an sgRNA with <3nt mismatch between homologs. 
 
IMPORTANT: Mismatches should not lie within the PAM sequence or 8-12 base pairs proximal 
to the PAM site when targeting both homologs. 
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Alternatively, choose a perfectly matched sgRNA for each homolog which will be injected together. 
In some cases, type and position of mismatch may either reduce or have no effect on efficiency 
(Doench et al., 2016). Here, sgRNAs were designed to target two different exons in X. laevis Dsp 
(Chapter 1, Table 1.3). 
 
B. SYNTHESIS OF sgRNA 
 
As stated above in Section I, the software generates a 5’-(N)20-NGG-3’ sequence, where NGG is 
the PAM sequence. This PAM sequence is required for targeted binding and cleavage by Cas9 
(Jinek et al., 2012; Sternberg et al., 2014). However, only the 5’-(N)20-3’ sequence is incorporated 
into the guide oligo.  
 
5. To the desired sgRNA sequence (without PAM), add AATTAATACGACTCACTATA to the 
5’ side and GTTTTAGAGCTAGAAATAGC to the 3’ side. This will result in an oligo that is 60 
bp long (5’-AATTAATACGACTCACTATA-(N)20-GTTTTAGAGCTAGAAATAGC-3’). 
 
The 5’-AATTAATACGACTCACTATA-3’ oligo on the 5’ side contains the T7 RNA polymerase 
minimal promoter sequence to facilitate transcription. The 5’-GTTTTAGAGCTAGAAATAGC-3’ 
oligo on the 3’ side is an overlap with the loop-sequence oligo. 
 
6. Order the 60 bp oligo above and the 80 bp scaffold oligo. 
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Since both oligos are long, PAGE purification was performed to remove smaller oligos that are a 
byproduct of synthesis. The scaffold oligo partially overlaps with the 60 bp oligo in Step 5 and 
contains the loop sequence for Cas9 interaction (Hsu et al., 2014; Jinek et al., 2012). 
 
7. Prepare both oligos as 100μM (stock concentration) and 10μM (working concentration) aliquots 
in nuclease-free water. 
 
Primers can be stored at -20°C. Stocks can even be stored at -80°C with minimal freeze-thaw 
cycles for longer shelf life. 
 
8. Synthesize the dsDNA template for transcription using the following Reaction mix and Protocol.  
 
Reaction mix: 
 
Reagents Volume 
2X Phusion Master Mix 12.5μl 
60 bp oligo (10μM) 5μl 
80 bp scaffold oligo (10μM) 5μl 
Nuclease-free water 2.5μl 
Total 25μl 
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Protocol: 
 
i. 98°C for 30s. 
ii. (98°C for 10s, 61°C for 10s, 72°C for 15s) X 45 cycles. 
iii. 72°C for 5 min. 
iv. 4°C hold. 
 
This reaction yields a 120 bp dsDNA PCR product. Optional: Run 1μl on a gel to ensure the 
product is synthesized and of appropriate size. 
 
9. Clean the PCR product using DNA concentrator columns, eluting and dissolving in the smallest 
volume of nuclease-free water. 
 
Measure concentration with a spectrophotometer. Ideally, a concentration of 200‐300 ng/μl 
should be achieved. 
 
10. Use the clean PCR product as the template for the RNA in vitro transcription (IVT) kit 
(MEGAscript T7) using ~100ng of the PCR product per reaction. Set up 2 reactions and pool 
together before next step. 
 
Follow manufacturer’s protocol for IVT. 
 
11. Stop the reaction by adding 1μl DNase and incubating at 37°C for 15 minutes. 
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12. Add 60μl Lithium chloride and 60μl nuclease-free water and incubate at -20°C overnight. 
 
13. Centrifuge at maximum speed at 4°C for 30 minutes. 
 
14. Remove supernatant.  
 
Pellet should be visible. If not, amount may be insufficient. Scale up IVT reaction as required. 
 
15. Add 1ml of freshly-prepared 70% ethanol and centrifuge at maximum speed at 4°C for 10 
minutes. 
 
16. Discard ethanol and spin for 10s at maximum speed to remove residual ethanol. 
 
17. Air dry and elute in 7-10μl nuclease-free water. 
 
Optional: Quantify a diluted sample. Store RNA at ‐80°C. 
 
C. MICROINJECTION OF XENOPUS EMBRYOS 
 
We performed titrations of sgRNA and Cas9 protein to rule out toxicity effects in addition to using 
multiple sgRNAs. The concentrations of sgRNA mentioned here were found to be appropriate for 
mutagenesis of Dsp. It is also recommended to first perform positive or negative controls 
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(preferably both) when determining the function of a gene not tested in Xenopus before. A positive 
control targets a gene that is thought to be involved in the same process as the gene of interest and 
allows setting a threshold for phenotypic screening. A negative control targets a gene not involved 
in that process and provides a measure of natural variability for that phenotype. It can also give 
information about toxicity or stress effects of the reagents or the injection itself (Shah et al., 2016). 
 
18. Prepare 830ng/μl aliquots of sgRNA (in nuclease-free water) and 2μg/μl aliquots of Cas9 
protein. 
 
Store sgRNA and Cas9 protein at ‐80°C, avoiding repeated freeze-thaw cycles. 
 
19. On the day of injection, mix Cas9 and sgRNA(s) to final concentration of 750ng/μl (Cas9) and 
500ng/μl (sgRNA). 
 
20. Inject ~2nl per embryo at 1-cell stage (1.5ng Cas9 and 1ng sgRNA/ embryo). Perform 
microinjections as described in Microinjection of Xenopus Embryos (Sive et al., 2010). 
 
The amount of sgRNA and Cas9 can depend on factors such as functional redundancy, and 
whether the protein function is cell-autonomous or can be rescued by wild-type cells. For best 
results, inject and culture embryos in 15°C 0.1X MBS to delay the first mitotic division. 
For mosaic embryos, perform injections at 4-cell stage. Alternatively, since fate maps are well-
characterized in X. laevis, perform injections at 16- to 32-cell stage to target only a specific subset 
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of cells or tissues (Dale and Slack, 1987; Moody, 1987; Moody and Kline, 1990). Adjust 
concentrations and injection volumes accordingly. 
 
D. DNA EXTRACTION FROM F0 MUTANT EMBRYOS 
 
A quick diagnostic test of successful mutation by CRISPR/ Cas9 is the presence of phenotypic 
changes. Dsp F0 mutants mimicked phenotypes observed in Dsp morphants but at lower 
prevalence (Chapter 1, Fig. 1.9-1.10). The tyrosinase genes, tyra and tyrb, were also targeted to 
determine the effect on morphology of F0 mutants (Wang et al., 2015). Embryos injected with 
sgRNAs targeting both tyra and tyrb developed normally except for defects in pigmentation 
patterns (Fig. 2.1B-D). Similar to reports in (Wang et al., 2015), there was phenotypic variability 
in the amount of pigmentation lost. 
However, absence of phenotypes suggests a number of explanations. As mentioned above, these 
may include low mutagenesis rate coupled with rescue by wild-type cells, and unknown 
functionally-redundant genes. Alternatively, the gene of interest may not be mutated at all. In most 
cases, DNA will have to be extracted to determine presence of mutations in the genome. 
 
21. Place one embryo per PCR tube on ice. Remove any medium with a pipette. 
 
Here, we use embryos at stage 30-31 (35-38hpf) but use any stage after stage 20 (22hpf) to obtain 
sufficient quantities of DNA.  
 
22. Add 35µl 1X Alkaline Lysis Buffer and heat at 95°C for 40 minutes. 
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Alkaline Lysis Buffer should be freshly prepared from 50X stock. Optional: Macerate embryos 
with a pestle to increase yield. 
 
23. Cool to 4°C. 
 
24. Add 35μl of 1X Neutralization Buffer. 
 
Neutralization Buffer should be freshly prepared from 50X stock. 
 
25. Vortex lightly and store at -20°C. Spin with centrifuge every time before usage. 
 
E. DETECTING MUTATIONS IN THE TARGET SEQUENCE 
To confirm that mutations have occurred in the target region, there are a number of methods such 
as high resolution melting (HRM) analysis and nuclease digest (Restriction Fragment Length 
Polymorphism). Here, we provide a modified T7 endonuclease I assay from New England Biolabs, 
Inc. (NEB) for fast and effective mutation analysis. This method relies on the random nature of 
different indels and heteroduplex formation (Mashal et al., 1995). 
 
26. Amplify the target region with specific primers using the following reaction mix and protocol.  
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Reaction mix: 
Reagents Volume 
2X Phusion Master Mix 15μl 
Sample DNA Variable (100ng) 
Primers (10μM) 3μl each 
Nuclease-free water To 30μl 
Total 30μl 
 
Protocol: 
 
i. 98°C for 30s. 
ii. (98°C for 5s, 61°C for 10s, 72°C for 20s) X 35 cycles. 
iii. 72°C for 120s. 
iv. 4°C hold. 
 
Primers should be designed to create products 200bp-1kb in size. Primers should be designed in 
such a way that the target site is off-center within the amplicon so that digestion produces easily 
resolvable DNA fragments. 
IMPORTANT: At least one primer in the primer pair should be sufficiently different to be able to 
distinguish between L and S homologs. Additionally, design primers such that amplicons from L 
and S homologs are also distinctly different sizes to avoid ambiguity. Primer design for an sgRNA 
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targeting both desmoplakin homologs is provided in Table 1.4. Primer design for an sgRNA 
targeting both tyrosinase homologs is provided in Table 2.1. 
 
27. Clean the PCR product using DNA concentrator columns, eluting and dissolving in nuclease -
free water. 
 
28. Measure the concentration using a spectrophotometer. 
 
29. Analyze the purified PCR product for mutations. 
 
Reaction mix: 
 
Reagents Volume 
Purified PCR product Variable (200ng) 
10X NEBuffer 2 2μl 
Nuclease-free water To 19μl 
Total 19μl 
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Protocol: 
 
i. 95°C for 5 min. 
ii. 95°C-85°C @ -2°C/s. 
iii. 85°C-25°C @ -0.1°C/s.  
iv. 4°C hold. 
 
30. Add 1μl of T7 endonuclease I and incubate at 37°C for 15 min.  
 
31. Stop reaction by adding 1.5μl of 0.25 Na2+-EDTA. 
 
32. Run samples on an agarose gel to identify if mutations are present. 
 
If mutations are not present, only one band of expected size will be observed. If mutations are 
present, three bands are observed. The largest band is the expected amplicon size of the original 
target. The remaining two bands are the products of cleavage of unmatched heteroduplexes. Their 
combined size roughly equals the original size. An example for mutation analysis in the 
desmoplakin homologs is shown in Fig. 1.6. 
The T7 endonuclease I method is fast and requires no special equipment but does not provide 
information about the specific nature of the mutation(s). As an alternative, we have also sequenced 
the total PCR product to determine if mutations are present in the dsp.L homolog. However, 
sequencing a heterogeneous mix of templates results in ambiguous base calling (Fig. 2.2). 
Performing colony sequencing or Next Generation Sequencing of the PCR product mix can 
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provide the specific nature of the different mutations. The colony sequencing method still only 
provides a semi-quantitative measure of the mutation frequency. The NGS method is highly 
quantitative but is also expensive (Shah et al., 2016). 
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Figure 2.1: CRISPR/ Cas9 targeting of tyrosinase genes resulted in pigmentation defects. 
(A) Wild-type embryo with normal pigmentation in head and trunk melanocytes and Retinal 
Pigmented Epithelium of the eye. (B) tyra+tyrb CRISPR F0 mutants with severe loss of 
pigmentation in head and trunk melanocytes and RPE. (C) tyra+tyrb CRISPR F0 mutants with 
partial loss of pigmentation in head and trunk melanocytes and RPE. (D) tyra+tyrb CRISPR F0 
mutants with relatively normal pigmentation in head and trunk melanocytes and RPE. 
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Figure 2.2: CRISPR/ Cas9 induced mutations in target region of desmoplakin gene. 
(A) Chromatogram of wild-type dsp.L homolog within target region of DspCRISPR1 sgRNA. 
Target sequence is denoted by black double-headed arrow. (B-D) Chromatogram of DspCRISPR1 
F0 mutant dsp.L homolog within target region of DspCRISPR1 sgRNA in Embryo 1 (B), Embryo 
2 (C) and Embryo 3 (D). Red line indicates start position of sgRNA target in all samples. Bases 
are color-coded as follows: Guanine=Black; Adenine=Green; Cytosine=Blue; Thymine=Red. 
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Table 2.1: CRISPR gRNA sequences against tyrosinase homologs. 
gRNA gRNA sequence + PAM  
(5’ –> 3’) 
Tyra GGGTCGATGATAGAGAGGACTGG 
Tyrb GGCCCGTAGCAGAGCTGGTGAGG 
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DISCUSSION 
 
Xenopus laevis is an excellent and highly tractable model for the study of developmenta l 
processes. Some advantages include large egg size for microinjections, large brood size, and gene 
conservation. Still, constraints such as allotetraploidy, incompletely annotated genome, and time 
to reach sexual maturity had presented challenges for the generation of genetic mutants. However, 
recent developments have helped overcome some of these issues. For instance, open reading 
frames in the X. laevis (and related X. tropicalis) genomes are rapidly being annotated on the 
Xenopus genome database, Xenbase. This is tied with the identification of homologs on the Long 
(L) and Short (S) chromosomes of X. laevis in addition to information about expression patterns 
(Session et al., 2016). These milestones have made it possible to generate mutants and establish 
mutant lines in Xenopus (Shi et al., 2015b).  
The CRISPR/ Cas9 genome modification system was developed from an RNA-mediated 
adaptive defense system naturally present in bacteria and archaea (Jinek et al., 2012; Wiedenheft 
et al., 2012). Over the last five years, it has been employed for the creation of transgenic tissues 
and whole organisms (Cong et al., 2013). In comparison to other recent genome-editing techniques 
such as Zinc-finger nucleases (ZFN) and transcription activator-like effectors nucleases (TALEN), 
this system has proven to be fast, scalable, and relatively easy to engineer in most laboratories 
(Christian et al., 2010; Doudna and Charpentier, 2014; Miller et al., 2007; Miller et al., 2011; 
Porteus and Baltimore, 2003; Wood et al., 2011). It has already been widely used in cells, mice, 
Drosophila, C. elegans and zebrafish (Bassett et al., 2014; Friedland et al., 2013; Hisano et al., 
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2015; Yang et al., 2014). Until recently, morpholinos and TALENs were utilized for loss-of-
function studies and transgenics in zebrafish and Xenopus (Christian et al., 2010; Heasman, 2002; 
Nasevicius and Ekker, 2000). However, the CRISPR/ Cas9 system has been successfully used to 
generate F0 mutants in X. tropicalis and X. laevis (Banach et al., 2017; Bhattacharya et al., 2015; 
Nakayama et al., 2013; Wang et al., 2015). Additionally, other protocols exist for generation of 
germline mutants in Xenopus sp. (Aslan et al., 2017). 
In this protocol, we use an established PCR-based system of synthesizing a dsDNA 
template that is transcribed into the sgRNA with appropriate CRISPR-targeting sequences 
(Bhattacharya et al., 2015; Shah et al., 2016). This RNA is simply injected along with Cas9 protein 
into the embryo or oocyte. In comparison to using a plasmid-based delivery system for sgRNA or 
Cas9 mRNA, this method results in a relatively rapid rate of mutagenesis. Furthermore, the Cas9 
protein has reportedly less toxicity than the mRNA (Bhattacharya et al., 2015). Only the 20nt guide 
RNA will have to be custom-designed for the intended target. 
Here, we have targeted the desmosomal structural protein, desmoplakin. A higher 
concentration of sgRNA was necessary to see phenotypes when targeting dsp relative to 
tyrosinase. Similarly, other groups also use lower amounts of sgRNA when targeting tyrosinase 
(Bhattacharya et al., 2015; Wang et al., 2015). This is likely because of the cell-autonomous 
requirement for tyrosinase in melanophores (Cichorek et al., 2013; Iozumi et al., 1993). For 
instance, there is variability in pigmentation loss in Xenopus tyrosinase mutants. Desmoplakin is 
a structural cell junction protein and therefore desmoplakin loss may be necessary in a large 
contiguous patch of tissue for phenotypes to be visible. Thus, higher levels of sgRNA could be 
required due to rescue by neighboring wild-type cells in embryos with low dsp mutagenes is 
efficiency.  
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We provide a protocol for targeting both subgenome homologs and suggest methods to 
only target one of the two homologs if desired. Also, steps to design homolog-specific primers for 
mutation analysis are detailed here. Since the X. laevis is allotetraploid, many loci are present as 
four copies within two ancestral subgenomes (Matsuda et al., 2015; Uno et al., 2013). This may 
result in lack of phenotypes if both subgenome homologs are not targeted due to potential 
redundancy. This may not necessarily be the case for genes that have variable expression between 
subgenomes. An RNAseq transcriptome analysis details this variability between loci (Session et 
al., 2016). Additionally, some genes exist only as a diploid state on either the ‘L’ or ‘S’ 
chromosome (estimated to be 17-40% of genes) (Hellsten et al., 2007; Session et al., 2016; Uno et 
al., 2013). Therefore, taking into account these considerations while targeting a specific gene will 
facilitate efficient mutagenesis. 
Xenopus has historically been used extensively as a model to understand vertebrate 
development. Knowledge about fate maps also makes it suitable for targeted mutagenesis. This 
protocol can also be potentially used for other CRISPR/ Cas9 applications. For instance, CRISPR/ 
Cas9 can be used to generate knock-ins in Xenopus, which can be used to study the effects of 
polymorphisms associated with human disease (Aslan et al., 2017). Expressing fusion reporters in 
Xenopus has already been used to study Rho GTPase activity, cell shape changes, and other 
dynamic processes (Davidson et al., 2008; Stephenson and Miller, 2017). Combining CRISPR/ 
Cas9 with fusion reporter-knock-in has the potential benefit of stable expression over a longer 
period of development, although this remains to be tested. Applying transgenic approaches to 
Xenopus can further add to the multitude of advantages already present in this model.  
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APPENDIX 
 
A.1. MULTIPLE SEQUENCE ALIGNMENT OF DESMOPLAKIN PROTEIN 
REVEALED HIGHLY SIMILAR FUNCTIONAL DOMAINS 
Pairwise alignments of whole desmoplakin protein homologs against X. laevis Dsp.L 
revealed high sequence similarity. Multiple sequence alignments were performed using Clustal 
Omega against X. laevis Dsp.L to visualize the extent of similarity between the homologs (Fig. 
A.1).  Overall, the sequences shared large regions of similarity within local stretches. These large 
motifs correspond to important desmoplakin functional domains. This indicates that the X. laevis 
Dsp.L homolog is largely conserved at the domain level with mammalian counterparts suggesting 
a shared function.  
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Figure A.1: Multiple sequence alignment of desmoplakin protein across species revealed 
conserved sequence. Multiple sequence alignment of desmoplakin protein sequences in X. laevis 
Dsp.L, human and mouse was performed with Clustal Omega (EMBL-EBI) using the HHalign 
algorithm. The threshold for shading was set to 50% using the BOXSHADE tool (EMBL-EBI) in 
the Clustal Omega generated sequence alignment. Start and End amino acid coordinates are 
marked for all Dsp functional domains, including, Plakin domain, Rod domain, and C-terminal tail 
domains (A,B,C) using arrowheads. Black shading denotes residues identical to X. laevis Dsp.L. 
Gray shading denotes residues similar to X. laevis Dsp.L. 
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A.2. SEQUENCE ALIGNMENT OF XENOPUS DESMOPLAKIN HOMOLOGS 
REVEALED DIFFERENCES IN EXON NUMBER 
While the X. laevis S subgenome has experienced more deletions, genes retained on both 
subgenomes sometimes display differences in gene expression. Such homologous pairs are also 
predicted to differ in coding sequence length (Session et al., 2016). The X. laevis Dsp.S homolog 
had 96.5% of the length of the Dsp.L homolog. Therefore, alignments of the gene coding regions 
of X. laevis Dsp.L and Dsp.S were performed to determine where the deletions occurred in the 
coding region. Results revealed that while infrequent mismatches occurred in some regions, a very 
large gap was present only in Dsp.S (Fig. A.2). This gap coincided with exons 11 and 12 of X. 
laevis Dsp.L (Fig. A.3). This gap that is observed only in the X. laevis S homolog but not the L 
homolog suggests that ancestral deletions occurred in Dsp.S. 
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Figure A.2: Multiple sequence alignment of Xenopus desmoplakin protein revealed gap in 
Dsp.S. Multiple sequence alignment of desmoplakin protein sequences of X. laevis Dsp.L and X. 
laevis Dsp.S was performed with Clustal Omega (EMBL-EBI) using the HHalign algorithm. The 
threshold for shading was set to 50% using the BOXSHADE tool (EMBL-EBI) in the Clustal 
Omega generated sequence alignment. Black arrowheads denote exon 11 (X. laevis Dsp.L). White 
arrowheads denote exon 12 (X. laevis Dsp.L). Black shading denotes residues identical to each 
other. Gray shading denotes residues similar to each other. 
 
 
 
 
 
 
152 
 
 
 
 
Figure A.3: Multiple sequence alignment of Xenopus desmoplakin coding regions revealed 
gap in Dsp.S. Multiple sequence alignment of desmoplakin coding DNA sequences of X. laevis 
Dsp.L and X. laevis Dsp.S was performed with Clustal Omega (EMBL-EBI) using the HHalign 
algorithm. Black arrowheads denote exon 11 (X. laevis Dsp.L). White arrowheads denote exon 12 
(X. laevis Dsp.L). Asterisk denotes identical residues. 
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A.3. COMPARATIVE ANALYSIS OF PLAKIN SUBDOMAINS REVEALED 
SIMILARITY ACROSS SPECIES 
The results above revealed a high degree of similarity in plakin, rod and C-terminal 
domains across species. The plakin domain consists of six spectrin repeats and an Src homology 
3 domain (Fig. A.4). Therefore, performed pairwise alignments were performed between X. laevis 
Dsp.L and mammalian Dsp homologs to determine the homology of these regions. Results 
revealed that the SR34 domain of H. sapiens and M. musculus homologs each shared 88% 
similarity with the corresponding domain in X. laevis Dsp.L (Table A.1). The SR56 domain of H. 
sapiens and M. musculus homologs each shared 91% similarity with the corresponding domain in 
X. laevis Dsp.L. The SR78 domain of H. sapiens and M. musculus homologs each shared 70% 
similarity with the corresponding domain in X. laevis Dsp.L. The SR8-CT linker domain of H. 
sapiens and M. musculus homologs each shared 77% similarity with the corresponding domain in 
X. laevis Dsp.L. Comparative analysis of plakin subdomains between Dsp.L and Dsp.S also 
revealed a high level of similarity. An exception was the SR56 subdomain, which only shared 60% 
similarity. The predicted SH3 domain which lies within was truncated in Dsp.S (Fig. A.4). 
Together, these results indicate that the plakin subdomains share a high degree of similar ity 
between X. laevis Dsp.L and mammalian homologs. The Dsp.L and Dsp.S homologs shared 
overall high similarity except in one domain. This region is where the deletion in Dsp.S lies and 
very likely explains the relatively low homology. 
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Figure A.4: Comparative bioinformatics analysis of the plakin domain in the desmoplakin 
protein. (A) Comparative analysis of plakin subdomains in the desmoplakin protein between 
vertebrate species and the X. laevis dsp.L homolog. Numbers below boxes depict amino acid 
coordinates for each subdomain. SR=Spectrin Repeat; SH3=Src homology 3; CT=C-Termina l 
region. 
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Table A.1: Desmoplakin plakin subdomains comparative analysis against X. laevis Dsp.L. 
Organism SR34 
%Identity/ 
Similarity  
SR56 
%Identity/ 
Similarity 
SH3 
%Identity/ 
Similarity 
SR78 
%Identity/ 
Similarity 
SR8-CT 
%Identity/ 
Similarity 
X. laevis 
(Dsp.L) 100 100 100 100 100 
H. sapiens 
75.9/88.2 79.1/90.9 79.5/92.3 45.4/70.5 61.8/77.5 
M. musculus 
75.4/87.7 78.3/90.9 79.5/92.3 45.4/70.0 62.2/77.5 
X. laevis 
(Dsp.S) 
94.4/98.5 58.3/59.8 - 94.7/97.8 94.0/96.8 
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